Catharina Larsson

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Professor i medicinsk genetik
Forskargruppsledare för medicinsk genetik inom experimentell translationell cancerforskning med laborativ verksamhet i BioClinicum.
Biträdande prefekt vid Institutionen för onkologi-patologi med uppdrag om högre lärartjänster
KI-FoUU-grupps-ordförande vid ME klinisk patologi &
cancerdiagnostik
Lärarrepresentant i Fakultetsnämnden.

Utbildning
Läkarexamen 1985
Dr Med Sci vid KI 1989
Docent vid KI 1999
Professor i medicinsk genetik vid KI 2001

Akademiska priser och utmärkelser
Eric K. Fernströms pris för yngre forskare 2005
Invald medlem i Nobelförsamlingen 2005
Göran Gustafssons pris i medicinsk forskning 2006
Invald medlem i medicinska klassen vid KVA 2008

Forskningsbeskrivning

Grundläggande och translationella studier av tumörer i endokrina organ ffa sköldkörteln och binjurarna.

Artiklar

Article: EXPERIMENTAL CELL RESEARCH. 2023;433(2):113858

Ca2+-activated K+ channels modulate membrane potential in the human parathyroid cell: Possible role in exocytosis.

Bränström R; Vukojević V; Lu M; Shabo I; Mun H-C; Conigrave AD; Farnebo L-O; Larsson C
Article: JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY. 2023;71(8):451-458

5hmC Immunohistochemistry: A Predictor of TERT Promoter Mutational Status in Follicular Thyroid Carcinoma?

Hysek M; Hellgren SL; Condello V; Xu Y; Larsson C; Zedenius J; Juhlin CC
Article: DIAGNOSTIC CYTOPATHOLOGY. 2023;51(6):331-340

Digital droplet PCR TERT promoter mutational screening in fine needle aspiration cytology of thyroid lesions: A highly specific technique for pre-operative identification of high-risk cases.

Hysek M; Hellgren LS; Stenman A; Darai-Ramqvist E; Ljung E; Schliemann I; Condello V; Larsson C; Zedenius J; Jatta K; Juhlin CC
Article: ENDOCRINE PATHOLOGY. 2023;34(1):129-141

TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor Clinical Outcome?

Solhusløkk Höse K; Stenman A; Svahn F; Larsson C; Juhlin CC
Article: SCIENTIFIC REPORTS. 2023;13(1):1070

Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer.

Lindfors H; Karlsen M; Karlton E; Zedenius J; Larsson C; Ihre Lundgren C; Juhlin CC; Shabo I
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2022;61(5):140

Altered expression of the IGF2‑H19 locus and mitochondrial respiratory complexes in adrenocortical carcinoma.

Scicluna P; Caramuta S; Kjellin H; Xu C; Fröbom R; Akhtar M; Gao J; Shi H; Kjellman M; Almgren M; Höög A; Zedenius J; Ekström TJ; Bränström R; Lui W-O; Larsson C
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2022;107(10):2811-2821

Presentation, Management, and Outcomes of Urinary Bladder Paraganglioma: Results From a Multicenter Study.

Yu K; Ebbehøj AL; Obeid H; Vaidya A; Else T; Wachtel H; Main AM; Søndergaard E; Lehmann Christensen L; Juhlin C; Calissendorff J; Cohen DL; Bennett B; Andersen MS; Larsson C; Almeida MQ; Fishbein L; Boorjian SA; Young WF; Bancos I
Article: ENDOCRINE PATHOLOGY. 2022;33(2):231-242

Prognostic Utility of the Ki-67 Labeling Index in Follicular Thyroid Tumors: a 20-Year Experience from a Tertiary Thyroid Center.

Hellgren LS; Stenman A; Paulsson JO; Höög A; Larsson C; Zedenius J; Juhlin CC
Article: NATURE METABOLISM. 2022;4(6):739-758

Impaired oxygen-sensitive regulation of mitochondrial biogenesis within the von Hippel-Lindau syndrome.

Li S; Li W; Yuan J; Bullova P; Wu J; Zhang X; Liu Y; Plescher M; Rodriguez J; Bedoya-Reina OC; Jannig PR; Valente-Silva P; Yu M; Henriksson MA; Zubarev RA; Smed-Sörensen A; Suzuki CK; Ruas JL; Holmberg J; Larsson C; Christofer Juhlin C; von Kriegsheim A; Cao Y; Schlisio S
Article: BIOMEDICINE & PHARMACOTHERAPY. 2022;149:112796

Synergistic effects of telomerase reverse transcriptase and regulator of telomere elongation helicase 1 on aggressiveness and outcomes in adrenocortical carcinoma.

Yuan H; Wu Y; Wang J; Qin X; Huang Y; Yan L; Fana Y; Zedenius J; Juhlin CC; Larsson C; Lui W-O; Xu D
Article: BIOMEDICINES. 2022;10(5):1004

Whole-Exome Sequencing of Germline Variants in Non-BRCA Families with Hereditary Breast Cancer.

Liu Y; Helgadottir HT; Kharaziha P; Choi J; López-Giráldez F; Mane SM; Höiom V; Juhlin CC; Larsson C; Bajalica-Lagercrantz S
Article: CANCERS. 2022;14(6):1385

Downregulation and Hypermethylation of GABPB1 Is Associated with Aggressive Thyroid Cancer Features.

Xing X; Mu N; Yuan X; Wang N; Juhlin CC; Strååt K; Larsson C; Neo SY; Xu D
Article: ISCIENCE. 2021;24(11):103264

Merkel cell polyomavirus T-antigens regulate DICER1 mRNA stability and translation through HSC70.

Gao J; Shi H; Juhlin CC; Larsson C; Lui W-O
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(19):10600

Imatinib Regulates miR-483-3p and Mitochondrial Respiratory Complexes in Gastrointestinal Stromal Tumors.

Huang W-K; Shi H; Akçakaya P; Zeljic K; Gangaev A; Caramuta S; Yeh C-N; Bränström R; Larsson C; Lui W-O
Article: NATURE COMMUNICATIONS. 2021;12(1):5309

Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors.

Bedoya-Reina OC; Li W; Arceo M; Plescher M; Bullova P; Pui H; Kaucka M; Kharchenko P; Martinsson T; Holmberg J; Adameyko I; Deng Q; Larsson C; Juhlin CC; Kogner P; Schlisio S
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(12):6345

Association between Predicted Effects of TP53 Missense Variants on Protein Conformation and Their Phenotypic Presentation as Li-Fraumeni Syndrome or Hereditary Breast Cancer.

Liu Y; Axell O; van Leeuwen T; Konrat R; Kharaziha P; Larsson C; Wright APH; Bajalica-Lagercrantz S
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2021;557:14-19

Direct interaction of the ATP-sensitive K+ channel by the tyrosine kinase inhibitors imatinib, sunitinib and nilotinib.

Fröbom R; Berglund E; Aspinwall CA; Lui W-O; Nilsson I-L; Larsson C; Bränström R
Article: JOURNAL OF CLINICAL PATHOLOGY. 2021;75(10):jclinpath-2021-207631-662

Nuclear-specific accumulation of telomerase reverse transcriptase (TERT) mRNA in TERT promoter mutated follicular thyroid tumours visualised by in situ hybridisation: a possible clinical screening tool?

Hellgren LS; Olsson A; Kaufeldt A; Paulsson JO; Hysek M; Stenman A; Zedenius J; Larsson C; Höög A; Juhlin CC
Article: NUCLEIC ACIDS RESEARCH. 2021;49(5):2509-2521

Aberrant splicing in neuroblastoma generates RNA-fusion transcripts and provides vulnerability to spliceosome inhibitors.

Shi Y; Yuan J; Rraklli V; Maxymovitz E; Cipullo M; Liu M; Li S; Westerlund I; Bedoya-Reina OC; Bullova P; Rorbach J; Juhlin CC; Stenman A; Larsson C; Kogner P; O'Sullivan MJ; Schlisio S; Holmberg J
Article: JOURNAL OF MOLECULAR DIAGNOSTICS. 2021;23(2):212-222

Spatial Distribution Patterns of Clinically Relevant TERT Promoter Mutations in Follicular Thyroid Tumors of Uncertain Malignant Potential: Advantages of the Digital Droplet PCR Technique.

Hysek M; Jatta K; Hellgren LS; Stenman A; Larsson C; Zedenius J; Juhlin CC
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2020;21(21):E8072-8072

Activation of RAS Signalling is Associated with Altered Cell Adhesion in Phaeochromocytoma.

Rossitti HM; Dutta RK; Larsson C; Ghayee HK; Söderkvist P; Gimm O
Article: CANCERS. 2020;12(8):E2133-2133

PLEKHS1 Over-Expression is Associated with Metastases and Poor Outcomes in Papillary Thyroid Carcinoma.

Xing X; Mu N; Yuan X; Wang N; Juhlin CC; Strååt K; Larsson C; Xu D
Article: CELLS. 2020;9(6):E1333-1333

Heterogeneity of Metabolic Vulnerability in Imatinib -Resistant Gastrointestinal Stromal Tumor.

Huang W-K; Gao J; Chen Z; Shi H; Yuan J; Cui HL; Yeh C-N; Bränström R; Larsson C; Li S; Lui W-O
Article: ENDOCRINE-RELATED CANCER. 2020;27(5):295-308

GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours.

Paulsson JO; Wang N; Gao J; Stenman A; Zedenius J; Mu N; Lui W-O; Larsson C; Juhlin CC
Article: INTERNATIONAL JOURNAL OF CANCER. 2020;146(6):1652-1666

Merkel cell polyomavirus oncoproteins induce microRNAs that suppress multiple autophagy genes.

Kumar S; Xie H; Shi H; Gao J; Juhlin CC; Björnhagen V; Höög A; Lee L; Larsson C; Lui W-O
Article: EPIGENETICS. 2019;14(12):1224-1233

Telomerase activation in small intestinal neuroendocrine tumours is associated with aberrant TERT promoter methylation, but not hot-spot mutations.

Fotouhi O; Ghaderi M; Wang N; Zedenius J; Kjellman M; Xu D; Juhlin CC; Larsson C
Article: ONCOGENE. 2019;38(43):6881-6897

Proteomics identifies neddylation as a potential therapy target in small intestinal neuroendocrine tumors.

Fotouhi O; Kjellin H; Juhlin CC; Pan Y; Vesterlund M; Ghaderi M; Yousef A; Andersson-Sand H; Kharaziha P; Caramuta S; Kjellman M; Zedenius J; Larsson C; Orre LM
Article: CANCERS. 2019;11(10):E1443-1443

Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease.

Hysek M; Paulsson JO; Jatta K; Shabo I; Stenman A; Höög A; Larsson C; Zedenius J; Juhlin CC
Article: ENDOCRINE PATHOLOGY. 2019;30(3):246-248

TERT Promoter Mutation Spatial Heterogeneity in a Metastatic Follicular Thyroid Carcinoma: Implications for Clinical Work-Up.

Stenman A; Hysek M; Jatta K; Bränström R; Darai-Ramqvist E; Paulsson JO; Wang N; Larsson C; Zedenius J; Juhlin CC
Article: CLINICAL GENETICS. 2019;96(3):216-225

Functional characterization of novel germline TP53 variants in Swedish families.

Kharaziha P; Ceder S; Axell O; Krall M; Fotouhi O; Böhm S; Lain S; Borg Å; Larsson C; Wiman KG; Tham E; Bajalica-Lagercrantz S
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2019;116(34):16997-17006

EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance.

Li S; Rodriguez J; Li W; Bullova P; Fell SM; Surova O; Westerlund I; Topcic D; Bergsland M; Stenman A; Muhr J; Nistér M; Holmberg J; Juhlin CC; Larsson C; von Kriegsheim A; Kaelin WG; Schlisio S
Article: JAMA NETWORK OPEN. 2019;2(8):e198898

Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing Adrenalectomy.

Neumann HPH; Tsoy U; Bancos I; Amodru V; Walz MK; Tirosh A; Kaur RJ; McKenzie T; Qi X; Bandgar T; Petrov R; Yukina MY; Roslyakova A; van der Horst-Schrivers ANA; Berends AMA; Hoff AO; Castroneves LA; Ferrara AM; Rizzati S; Mian C; Dvorakova S; Hasse-Lazar K; Kvachenyuk A; Peczkowska M; Loli P; Erenler F; Krauss T; Almeida MQ; Liu L; Zhu F; Recasens M; Wohllk N; Corssmit EPM; Shafigullina Z; Calissendorff J; Grozinsky-Glasberg S; Kunavisarut T; Schalin-Jäntti C; Castinetti F; Vlcek P; Beltsevich D; Egorov VI; Schiavi F; Links TP; Lechan RM; Bausch B; Young WF; Eng C; International Bilateral-Pheochromocytoma-Registry
Article: ANTICANCER RESEARCH. 2019;39(7):3433-3442

Biochemical Inhibition of DOG1/TMEM16A Achieves Antitumoral Effects in Human Gastrointestinal Stromal Tumor Cells In Vitro.

Fröbom R; Sellberg F; Xu C; Zhao A; Larsson C; Lui W-O; Nilsson I-L; Berglund E; Bränström R
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2019;43(3):409-421

Molecular Profiling of Pheochromocytoma and Abdominal Paraganglioma Stratified by the PASS Algorithm Reveals Chromogranin B as Associated With Histologic Prediction of Malignant Behavior.

Stenman A; Svahn F; Hojjat-Farsangi M; Zedenius J; Söderkvist P; Gimm O; Larsson C; Juhlin CC
Article: ONCOGENE. 2019;38(7):965-979

GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.

Yuan X; Mu N; Wang N; Strååt K; Sofiadis A; Guo Y; Stenman A; Li K; Cheng G; Zhang L; Kong F; Ekblad L; Wennerberg J; Nilsson I-L; Juhlin CC; Larsson C; Xu D
Article: CANCERS. 2018;10(11):E443-443

MiR-375 Regulation of LDHB Plays Distinct Roles in Polyomavirus-Positive and -Negative Merkel Cell Carcinoma.

Kumar S; Xie H; Scicluna P; Lee L; Björnhagen V; Höög A; Larsson C; Lui W-O
Article: EXPERIMENTAL CELL RESEARCH. 2018;371(1):287-296

miR-125a-5p regulation increases phosphorylation of FAK that contributes to imatinib resistance in gastrointestinal stromal tumors.

Huang W-K; Akçakaya P; Gangaev A; Lee L; Zeljic K; Hajeri P; Berglund E; Ghaderi M; Åhlén J; Bränström R; Larsson C; Lui W-O
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2018;42(3):1675-1683

TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma.

Svahn F; Paulsson JO; Stenman A; Fotouhi O; Mu N; Murtha TD; Korah R; Carling T; Bäckdahl M; Wang N; Juhlin CC; Larsson C
Article: ENDOCRINE. 2018;61(2):293-302

High Ki-67 index in fine needle aspiration cytology of follicular thyroid tumors is associated with increased risk of carcinoma.

Mu N; Juhlin CC; Tani E; Sofiadis A; Reihnér E; Zedenius J; Larsson C; Nilsson I-L
Article: WORLD JOURNAL OF SURGERY. 2018;42(8):2512-2521

Wide Surgical Margin Improves the Outcome for Patients with Gastrointestinal Stromal Tumors (GISTs).

Åhlén J; Karlsson F; Wejde J; Nilsson I-L; Larsson C; Bränström R
Article: MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2018;470:84-95

Molecular profiles of oxyphilic and chief cell parathyroid adenoma.

Lu M; Kjellin H; Fotouhi O; Lee L; Nilsson I-L; Haglund F; Höög A; Lehtiö J; Larsson C
Article: ENDOCRINE-RELATED CANCER. 2018;25(7):723-733

TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours.

Paulsson JO; Mu N; Shabo I; Wang N; Zedenius J; Larsson C; Juhlin CC
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2018;103(7):2640-2650

Comprehensive Genetic Analysis of Follicular Thyroid Carcinoma Predicts Prognosis Independent of Histology.

Nicolson NG; Murtha TD; Dong W; Paulsson JO; Choi J; Barbieri AL; Brown TC; Kunstman JW; Larsson C; Prasad ML; Korah R; Lifton RP; Juhlin CC; Carling T
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2018;52(4):1189-1197

LRIG1 negatively regulates RET mutants and is downregulated in thyroid cancer.

Lindquist D; Alsina FC; Herdenberg C; Larsson C; Höppener J; Wang N; Paratcha G; Tarján M; Tot T; Henriksson R; Hedman H
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2018;52(1):55-66

MicroRNA expression profiles in non‑epithelial ovarian tumors.

Chang RK; Li X; Mu N; Hrydziuszko O; Garcia-Majano B; Larsson C; Lui W-O
Article: PATHOBIOLOGY. 2018;85(4):211-219

Proteomic Profiling of Diffuse Large B-Cell Lymphomas.

Kwiecińska A; Porwit A; Souchelnytskyi N; Kaufeldt A; Larsson C; Bajalica-Lagercrantz S; Souchelnytskyi S
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2017;177(6):445-453

Inflammatory infiltrates in parathyroid tumors.

Haglund F; Hallström BM; Nilsson I-L; Höög A; Juhlin CC; Larsson C
Article: ONCOLOGIST. 2017;22(10):1178-1188

TERT Promoter Hypermethylation in Gastrointestinal Cancer: A Potential Stool Biomarker.

Liu L; Liu C; Fotouhi O; Fan Y; Wang K; Xia C; Shi B; Zhang G; Wang K; Kong F; Larsson C; Hu S; Xu D
Article: JAMA ONCOLOGY. 2017;3(9):1204-1212

Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.

Bausch B; Schiavi F; Ni Y; Welander J; Patocs A; Ngeow J; Wellner U; Malinoc A; Taschin E; Barbon G; Lanza V; Söderkvist P; Stenman A; Larsson C; Svahn F; Chen J-L; Marquard J; Fraenkel M; Walter MA; Peczkowska M; Prejbisz A; Jarzab B; Hasse-Lazar K; Petersenn S; Moeller LC; Meyer A; Reisch N; Trupka A; Brase C; Galiano M; Preuss SF; Kwok P; Lendvai N; Berisha G; Makay Ö; Boedeker CC; Weryha G; Racz K; Januszewicz A; Walz MK; Gimm O; Opocher G; Eng C; Neumann HPH; European-American-Asian Pheochromocytoma-Paragangl
Article: CELL DEATH & DISEASE. 2017;8(5):e2759

Loss of miR-514a-3p regulation of PEG3 activates the NF-kappa B pathway in human testicular germ cell tumors.

Özata DM; Li X; Lee L; Liu J; Warsito D; Hajeri P; Hultman I; Fotouhi O; Marklund S; Ährlund-Richter L; Juhlin CC; Larsson C; Lui W-O
Article: ONCOLOGY LETTERS. 2017;13(5):3586-3598

Evaluation of microRNA-205 expression as a potential triage marker for patients with low-grade squamous intraepithelial lesions.

Xie H; Norman I; Hjerpe A; Vladic T; Larsson C; Lui W-O; Östensson E; Andersson S
Article: BMC CANCER. 2017;17(1):164

A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis.

Cheng JY; Brown TC; Murtha TD; Stenman A; Juhlin CC; Larsson C; Healy JM; Prasad ML; Knoefel WT; Krieg A; Scholl UI; Korah R; Carling T
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2017;50(2):356-364

miR‑223‑3p regulates cell growth and apoptosis via FBXW7 suggesting an oncogenic role in human testicular germ cell tumors.

Liu J; Shi H; Li X; Chen G; Larsson C; Lui W-O
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2016;101(10):3616-3627

Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors.

Fotouhi O; Kjellin H; Larsson C; Hashemi J; Barriuso J; Juhlin CC; Lu M; Höög A; Pastrián LG; Lamarca A; Soto VH; Zedenius J; Mendiola M; Lehtiö J; Kjellman M
Article: ENDOCRINE. 2016;53(2):505-511

Minimally invasive follicular thyroid carcinomas: prognostic factors.

Stenson G; Nilsson I-L; Mu N; Larsson C; Lundgren CI; Juhlin CC; Höög A; Zedenius J
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2016;174(5):583-590

Diffuse parathyroid hormone expression in parathyroid tumors argues against important functional tumor subclones.

Haglund F; Juhlin CC; Kiss NB; Larsson C; Nilsson I-L; Höög A
Article: GENES CHROMOSOMES & CANCER. 2016;55(5):452-459

HRAS mutation prevalence and associated expression patterns in pheochromocytoma.

Stenman A; Welander J; Gustavsson I; Brunaud L; Bäckdahl M; Söderkvist P; Gimm O; Juhlin CC; Larsson C
Article: ONCOTARGET. 2016;7(16):21332-21346

Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma.

Wang N; Kjellin H; Sofiadis A; Fotouhi O; Juhlin CC; Bäckdahl M; Zedenius J; Xu D; Lehtiö J; Larsson C
Article: PLOS ONE. 2016;11(9):e0162379

Human Cytochrome P450 2W1 Is Not Expressed in Adrenal Cortex and Is Only Rarely Expressed in Adrenocortical Carcinomas.

Nolé P; Duijndam B; Stenman A; Juhlin CC; Kozyra M; Larsson C; Ingelman-Sundberg M; Johansson I
Article: EXPERIMENTAL CELL RESEARCH. 2015;336(1):158-170

Secretome protein signature of human gastrointestinal stromal tumor cells.

Berglund E; Daré E; Branca RMM; Akcakaya P; Fröbom R; Berggren P-O; Lui W-O; Larsson C; Zedenius J; Orre L; Lehtiö J; Kim J; Bränström R
Article: HUMAN MOLECULAR GENETICS. 2015;24(8):2318-2329

Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.

Kunstman JW; Juhlin CC; Goh G; Brown TC; Stenman A; Healy JM; Rubinstein JC; Choi M; Kiss N; Nelson-Williams C; Mane S; Rimm DL; Prasad ML; Höög A; Zedenius J; Larsson C; Korah R; Lifton RP; Carling T
Article: INTERNATIONAL JOURNAL OF CANCER. 2015;136(5):E230-E241

Novel functions and targets of miR-944 in human cervical cancer cells.

Xie H; Lee L; Scicluna P; Kavak E; Larsson C; Sandberg R; Lui W-O
Article: ENDOCRINE CONNECTIONS. 2015;4(1):76-85

Tumour nuclear oestrogen receptor beta 1 correlates inversely with parathyroid tumour weight.

Haglund F; Rosin G; Nilsson I-L; Juhlin CC; Pernow Y; Norenstedt S; Dinets A; Larsson C; Hartman J; Höög A
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2015;100(3):E493-E502

Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.

Juhlin CC; Goh G; Healy JM; Fonseca AL; Scholl UI; Stenman A; Kunstman JW; Brown TC; Overton JD; Mane SM; Nelson-Williams C; Bäckdahl M; Suttorp A-C; Haase M; Choi M; Schlessinger J; Rimm DL; Höög A; Prasad ML; Korah R; Larsson C; Lifton RP; Carling T
Article: PLOS ONE. 2015;10(5):e0126472

Differential protein expression profiles of cyst fluid from papillary thyroid carcinoma and benign thyroid lesions.

Dinets A; Pernemalm M; Kjellin H; Sviatoha V; Sofiadis A; Juhlin CC; Zedenius J; Larsson C; Lehtiö J; Höög A
Article: BRITISH JOURNAL OF CANCER. 2014;111(11):2091-2102

microRNA expression signatures of gastrointestinal stromal tumours: associations with imatinib resistance and patient outcome.

Akçakaya P; Caramuta S; Åhlen J; Ghaderi M; Berglund E; Östman A; Bränström R; Larsson C; Lui W-O
Article: CLINICAL CANCER RESEARCH. 2014;20(22):5733-5744

Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells.

Wennerberg E; Pfefferle A; Ekblad L; Yoshimoto Y; Kremer V; Kaminskyy VO; Juhlin CC; Höög A; Bodin I; Svjatoha V; Larsson C; Zedenius J; Wennerberg J; Lundqvist A
Article: ONCOTARGET. 2014;5(20):10048-10057

TERT promoter mutations and gene amplification: promoting TERT expression in Merkel cell carcinoma.

Xie H; Liu T; Wang N; Björnhagen V; Höög A; Larsson C; Lui W-O; Xu D
Article: ONCOGENE. 2014;33(42):4978-4984

The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.

Liu T; Wang N; Cao J; Sofiadis A; Dinets A; Zedenius J; Larsson C; Xu D
Article: CANCER. 2014;120(19):2965-2979

TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.

Wang N; Liu T; Sofiadis A; Juhlin CC; Zedenius J; Höög A; Larsson C; Xu D
Article: GENES CHROMOSOMES & CANCER. 2014;53(9):750-768

Amplification of 2p as a genomic marker for transformation in lymphoma.

Kwiecinska A; Ichimura K; Berglund M; Dinets A; Sulaiman L; Collins VP; Larsson C; Porwit A; Lagercrantz SB
Article: EXPERIMENTAL CELL RESEARCH. 2014;326(2):315-325

Functional role of the Ca²⁺-activated Cl⁻ channel DOG1/TMEM16A in gastrointestinal stromal tumor cells.

Berglund E; Akcakaya P; Berglund D; Karlsson F; Vukojević V; Lee L; Bogdanović D; Lui W-O; Larsson C; Zedenius J; Fröbom R; Bränström R
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2014;99(8):E1571-E1579

Telomerase-dependent and independent telomere maintenance and its clinical implications in medullary thyroid carcinoma.

Wang N; Xu D; Sofiadis A; Höög A; Vukojević V; Bäckdahl M; Zedenius J; Larsson C
Article: EPIGENETICS. 2014;9(7):987-997

Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study.

Fotouhi O; Adel Fahmideh M; Kjellman M; Sulaiman L; Höög A; Zedenius J; Hashemi J; Larsson C
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2014;99(7):E1352-E1360

Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma.

Welander J; Andreasson A; Juhlin CC; Wiseman RW; Bäckdahl M; Höög A; Larsson C; Gimm O; Söderkvist P
Article: ENDOCRINE-RELATED CANCER. 2014;21(3):427-434

The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors.

Liu T; Brown TC; Juhlin CC; Andreasson A; Wang N; Bäckdahl M; Healy JM; Prasad ML; Korah R; Carling T; Xu D; Larsson C
Article: ENDOCRINE-RELATED CANCER. 2014;21(3):495-504

Frequent EPAS1/HIF2α exons 9 and 12 mutations in non-familial pheochromocytoma.

Welander J; Andreasson A; Brauckhoff M; Bäckdahl M; Larsson C; Gimm O; Söderkvist P
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2014;170(4):583-591

MicroRNA expression patterns associated with hyperfunctioning and non-hyperfunctioning phenotypes in adrenocortical adenomas.

Velázquez-Fernández D; Caramuta S; Özata DM; Lu M; Höög A; Bäckdahl M; Larsson C; Lui W-O; Zedenius J
Article: ANTI-CANCER DRUGS. 2014;25(4):415-422

Intracellular concentration of the tyrosine kinase inhibitor imatinib in gastrointestinal stromal tumor cells.

Berglund E; Ubhayasekera SJKA; Karlsson F; Akcakaya P; Aluthgedara W; Ahlen J; Fröbom R; Nilsson I-L; Lui W-O; Larsson C; Zedenius J; Bergquist J; Bränström R
Article: WORLD JOURNAL OF SURGERY. 2014;38(3):724-732

Role of SDHAF2 and SDHD in von Hippel-Lindau associated pheochromocytomas.

Kugelberg J; Welander J; Schiavi F; Fassina A; Bäckdahl M; Larsson C; Opocher G; Söderkvist P; Dahia PL; Neumann HPH; Gimm O
Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2014;134(2):507-517

MicroRNA expression patterns related to merkel cell polyomavirus infection in human merkel cell carcinoma.

Xie H; Lee L; Caramuta S; Höög A; Browaldh N; Björnhagen V; Larsson C; Lui W-O
Article: PLOS ONE. 2014;9(11):e111125

Expression of the p53 target Wig-1 is associated with HPV status and patient survival in cervical carcinoma.

Xu L-D; Muller S; Thoppe SR; Hellborg F; Kanter L; Lerner M; Zheng B; Lagercrantz SB; Grandér D; Wallin KL; Wiman KG; Larsson C; Andersson S
Article: EPIGENETICS. 2013;8(12):1347-1354

The VHL gene is epigenetically inactivated in pheochromocytomas and abdominal paragangliomas.

Andreasson A; Kiss NB; Caramuta S; Sulaiman L; Svahn F; Bäckdahl M; Höög A; Juhlin CC; Larsson C
Article: BMC CANCER. 2013;13:505

Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization.

Hashemi J; Fotouhi O; Sulaiman L; Kjellman M; Höög A; Zedenius J; Larsson C
Article: BLOOD CANCER JOURNAL. 2013;3(10):e152

Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma.

Caramuta S; Lee L; Ozata DM; Akçakaya P; Georgii-Hemming P; Xie H; Amini R-M; Lawrie CH; Enblad G; Larsson C; Berglund M; Lui W-O
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2013;98(8):E1345-E1351

Inhibition of parathyroid hormone secretion by caffeine in human parathyroid cells.

Lu M; Farnebo L-O; Bränström R; Larsson C
Article: ENDOCRINE-RELATED CANCER. 2013;20(4):551-564

Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma.

Caramuta S; Lee L; Ozata DM; Akçakaya P; Xie H; Höög A; Zedenius J; Bäckdahl M; Larsson C; Lui W-O
Article: EPIGENETICS. 2013;8(6):646-655

Global and gene-specific promoter methylation analysis in primary hyperparathyroidism.

Sulaiman L; Juhlin CC; Nilsson I-L; Fotouhi O; Larsson C; Hashemi J
Article: EXPERIMENTAL CELL RESEARCH. 2013;319(8):1229-1238

Evidence for Ca(2+)-regulated ATP release in gastrointestinal stromal tumors.

Berglund E; Berglund D; Akcakaya P; Ghaderi M; Daré E; Berggren P-O; Köhler M; Aspinwall CA; Lui W-O; Zedenius J; Larsson C; Bränström R
Article: ENDOCRINE-RELATED CANCER. 2013;20(1):65-78

Acquired hypermethylation of the P16INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation.

Kiss NB; Muth A; Andreasson A; Juhlin CC; Geli J; Bäckdahl M; Höög A; Wängberg B; Nilsson O; Ahlman H; Larsson C
Article: NEUROENDOCRINOLOGY. 2013;97(1):19-25

Epigenetic aspects on therapy development for gastroenteropancreatic neuroendocrine tumors.

Larsson C
Article: JOURNAL OF SURGICAL ONCOLOGY. 2012;106(8):981-986

Anaplastic carcinoma of the thyroid gland: treatment and outcome over 13 years at one institution.

Segerhammar I; Larsson C; Nilsson I-L; Bäckdahl M; Höög A; Wallin G; Foukakis T; Zedenius J
Article: HUMAN MOLECULAR GENETICS. 2012;21(26):5406-5416

Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas.

Welander J; Larsson C; Bäckdahl M; Hareni N; Sivlér T; Brauckhoff M; Söderkvist P; Gimm O
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2012;41(6):1959-1966

Cell type and context-specific function of PLAG1 for IGF2 P3 promoter activity.

Akhtar M; Holmgren C; Göndör A; Vesterlund M; Kanduri C; Larsson C; Ekström TJ
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2012;97(12):4631-4639

Evidence of a functional estrogen receptor in parathyroid adenomas.

Haglund F; Ma R; Huss M; Sulaiman L; Lu M; Nilsson I-L; Höög A; Juhlin CC; Hartman J; Larsson C
Article: BMC MEDICAL GENETICS. 2012;13:83

Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas.

Kiss NB; Kogner P; Johnsen JI; Martinsson T; Larsson C; Geli J
Article: FAMILIAL CANCER. 2012;11(3):355-362

Molecular characterization of parathyroid tumors from two patients with hereditary colorectal cancer syndromes.

Andreasson A; Sulaiman L; do Vale S; Martins JM; Ferreira F; Miltenberger-Miltenyi G; Batista L; Haglund F; Björck E; Nilsson I-L; Höög A; Larsson C; Juhlin CC
Article: ENDOCRINE-RELATED CANCER. 2012;19(3):389-407

Genetic characterization of large parathyroid adenomas.

Sulaiman L; Nilsson I-L; Juhlin CC; Haglund F; Höög A; Larsson C; Hashemi J
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2012;166(6):1049-1060

Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma.

Dinets A; Hulchiy M; Sofiadis A; Ghaderi M; Höög A; Larsson C; Zedenius J
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2012;166(4):657-667

Proteomic profiling of follicular and papillary thyroid tumors.

Sofiadis A; Becker S; Hellman U; Hultin-Rosenberg L; Dinets A; Hulchiy M; Zedenius J; Wallin G; Foukakis T; Höög A; Auer G; Lehtiö J; Larsson C
Article: PLOS ONE. 2012;7(9):e46325

Genome-wide and locus specific alterations in CDC73/HRPT2-mutated parathyroid tumors.

Sulaiman L; Haglund F; Hashemi J; Obara T; Nordenström J; Larsson C; Juhlin CC
Article: PLOS ONE. 2012;7(10):e46990

miR-205 expression promotes cell proliferation and migration of human cervical cancer cells.

Xie H; Zhao Y; Caramuta S; Larsson C; Lui W-O
Article: PLOS ONE. 2012;7(5):e36448

Prolactin receptor in primary hyperparathyroidism--expression, functionality and clinical correlations.

Haglund F; Lu M; Vukojević V; Nilsson I-L; Andreasson A; Džabić M; Bränström R; Höög A; Juhlin CC; Larsson C
Article: MOLECULAR ENDOCRINOLOGY. 2011;25(12):2017-2028

Epigenetic regulation of glucose transporter 4 by estrogen receptor β.

Rüegg J; Cai W; Karimi M; Kiss NB; Swedenborg E; Larsson C; Ekström TJ; Pongratz I
Article: ENDOCRINE-RELATED CANCER. 2011;18(6):643-655

The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.

Özata DM; Caramuta S; Velázquez-Fernández D; Akçakaya P; Xie H; Höög A; Zedenius J; Bäckdahl M; Larsson C; Lui W-O
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2011;411(1):208-212

Enhanced effects by 4-phenylbutyrate in combination with RTK inhibitors on proliferation in brain tumor cell models.

Marino A-M; Sofiadis A; Baryawno N; Johnsen JI; Larsson C; Vukojević V; Ekström TJ
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2011;411(1):156-161

The pattern of gene expression and gene dose profiles of 6-Mercaptopurine- and 6-Thioguanine-resistant human leukemia cells.

Karim H; Hashemi J; Larsson C; Moshfegh A; Fotoohi AK; Albertioni F
Article: VIRCHOWS ARCHIV. 2011;459(1):47-53

Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours.

Juhlin CC; Haglund F; Obara T; Arnold A; Larsson C; Höög A
Article: PLOS ONE. 2011;6(3):e14757

Molecular characterization of acquired tolerance of tumor cells to picropodophyllin (PPP).

Hashemi J; Worrall C; Vasilcanu D; Fryknäs M; Sulaiman L; Karimi M; Weng W-H; Lui W-O; Rudduck C; Axelson M; Jernberg-Wiklund H; Girnita L; Larsson O; Larsson C
Article: JOURNAL OF ENDOCRINOLOGY. 2011;208(1):31-39

Calmodulin and calmodulin-dependent protein kinase II inhibit hormone secretion in human parathyroid adenoma.

Lu M; Berglund E; Larsson C; Höög A; Farnebo L-O; Bränström R
Article: THYROID. 2010;20(10):1067-1076

Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca2+ -binding protein S100A6 in papillary thyroid carcinoma.

Sofiadis A; Dinets A; Orre LM; Branca RM; Juhlin CC; Foukakis T; Wallin G; Höög A; Hulchiy M; Zedenius J; Larsson C; Lehtiö J
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2010;37(5):1323-1330

Suppression of RIZ in biologically unfavourable neuroblastomas.

Geli J; Kiss N; Kogner P; Larsson C
Article: ENDOCRINE PATHOLOGY. 2010;21(3):166-177

Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas.

Juhlin CC; Nilsson I-L; Johansson K; Haglund F; Villablanca A; Höög A; Larsson C
Article: ENDOCRINE-RELATED CANCER. 2010;17(3):561-579

Recurrent genomic alterations in benign and malignant pheochromocytomas and paragangliomas revealed by whole-genome array comparative genomic hybridization analysis.

Sandgren J; Diaz de Ståhl T; Andersson R; Menzel U; Piotrowski A; Nord H; Bäckdahl M; Kiss NB; Brauckhoff M; Komorowski J; Dralle H; Hessman O; Larsson C; Akerström G; Bruder C; Dumanski JP; Westin G
Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2010;130(8):2062-2070

MicroRNA expression profiles associated with mutational status and survival in malignant melanoma.

Caramuta S; Egyházi S; Rodolfo M; Witten D; Hansson J; Larsson C; Lui W-O
Article: JOURNAL OF MOLECULAR ENDOCRINOLOGY. 2010;44(5):285-294

Expression and association of TRPC subtypes with Orai1 and STIM1 in human parathyroid.

Lu M; Bränström R; Berglund E; Höög A; Björklund P; Westin G; Larsson C; Farnebo L-O; Forsberg L
Article: PLOS ONE. 2010;5(3):e9472

Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours.

Juhlin CC; Kiss NB; Villablanca A; Haglund F; Nordenström J; Höög A; Larsson C
Article: AMERICAN JOURNAL OF PATHOLOGY. 2009;175(5):1831-1847

Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears.

Andersson S; Sowjanya P; Wangsa D; Hjerpe A; Johansson B; Auer G; Gravitt PE; Larsson C; Wallin K-L; Ried T; Heselmeyer-Haddad K
Article: AMERICAN JOURNAL OF HUMAN GENETICS. 2009;85(5):617-627

Autosomal-dominant retinitis pigmentosa caused by a mutation in SNRNP200, a gene required for unwinding of U4/U6 snRNAs.

Zhao C; Bellur DL; Lu S; Zhao F; Grassi MA; Bowne SJ; Sullivan LS; Daiger SP; Chen LJ; Pang CP; Zhao K; Staley JP; Larsson C
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2009;161(1):141-152

Transcriptional profiling enables molecular classification of adrenocortical tumours.

Laurell C; Velázquez-Fernández D; Lindsten K; Juhlin C; Enberg U; Geli J; Höög A; Kjellman M; Lundeberg J; Hamberger B; Larsson C; Nilsson P; Bäckdahl M
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2009;35(2):369-374

Diagnostic and prognostic potential of MIB-1 proliferation index in thyroid fine needle aspiration biopsy.

Sofiadis A; Tani E; Foukakis T; Kjellman P; Skoog L; Höög A; Wallin G; Zedenius J; Larsson C
Article: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 2009;32(6):512-518

Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.

Vierimaa O; Villablanca A; Alimov A; Georgitsi M; Raitila A; Vahteristo P; Larsson C; Ruokonen A; Eloranta E; Ebeling TML; Ignatius J; Aaltonen LA; Leisti J; Salmela PI
Article: BIOCHEMICAL PHARMACOLOGY. 2009;77(8):1410-1417

Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis.

Fotoohi AK; Assaraf YG; Moshfegh A; Hashemi J; Jansen G; Peters GJ; Larsson C; Albertioni F
Article: INTERNATIONAL JOURNAL OF CANCER. 2008;123(5):1190-1195

Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy.

Daneshmanesh AH; Mikaelsson E; Jeddi-Tehrani M; Bayat AA; Ghods R; Ostadkarampour M; Akhondi M; Lagercrantz S; Larsson C; Osterborg A; Shokri F; Mellstedt H; Rabbani H
Article: CANCER RESEARCH. 2008;68(17):7156-7164

CREB3L2-PPARgamma fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis.

Lui W-O; Zeng L; Rehrmann V; Deshpande S; Tretiakova M; Kaplan EL; Leibiger I; Leibiger B; Enberg U; Höög A; Larsson C; Kroll TG
Article: ENDOCRINE-RELATED CANCER. 2008;15(3):801-815

Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma.

Lee J-J; Au AYM; Foukakis T; Barbaro M; Kiss N; Clifton-Bligh R; Staaf J; Borg A; Delbridge L; Robinson BG; Wallin G; Höög A; Larsson C
Article: INTERNATIONAL JOURNAL OF CANCER. 2008;123(2):389-394

Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma.

Geli J; Kogner P; Lanner F; Natalishvili N; Juhlin C; Kiss N; Clark GJ; Ekström TJ; Farnebo F; Larsson C
Article: MOLECULAR AND CELLULAR ENDOCRINOLOGY. 2008;287(1-2):72-80

Heterogeneous expression of SNARE proteins SNAP-23, SNAP-25, Syntaxin1 and VAMP in human parathyroid tissue.

Lu M; Forsberg L; Höög A; Juhlin CC; Vukojević V; Larsson C; Conigrave AD; Delbridge LW; Gill A; Bark C; Farnebo L-O; Bränström R
Article: ENDOCRINE-RELATED CANCER. 2008;15(2):609-621

Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas.

Kiss NB; Geli J; Lundberg F; Avci C; Velazquez-Fernandez D; Hashemi J; Weber G; Höög A; Ekström TJ; Bäckdahl M; Larsson C
Article: JOURNAL OF PATHOLOGY. 2008;215(1):87-96

Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.

Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S
Article: CLINICAL CANCER RESEARCH. 2008;14(9):2551-2559

Global and regional CpG methylation in pheochromocytomas and abdominal paragangliomas: association to malignant behavior.

Geli J; Kiss N; Karimi M; Lee J-J; Bäckdahl M; Ekström TJ; Larsson C
Article: EUROPEAN JOURNAL OF ORTHODONTICS. 2008;30(2):169-175

Familial non-syndromic cleft lip and palate--analysis of the IRF6 gene and clinical phenotypes.

Pegelow M; Peyrard-Janvid M; Zucchelli M; Fransson I; Larson O; Kere J; Larsson C; Karsten A
Article: ARCHIVES OF OPHTHALMOLOGY. 2008;126(3):388-394

Novel and recurrent KIF21A mutations in congenital fibrosis of the extraocular muscles type 1 and 3.

Lu S; Zhao C; Zhao K; Li N; Larsson C
Article: LEUKEMIA & LYMPHOMA. 2008;49(3):477-487

Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia.

Thelander EF; Ichimura K; Corcoran M; Barbany G; Nordgren A; Heyman M; Berglund M; Mungall A; Rosenquist R; Collins VP; Grandér D; Larsson C; Lagercrantz S
Article: LEUKEMIA RESEARCH. 2007;31(9):1219-1230

Detailed assessment of copy number alterations revealing homozygous deletions in 1p and 13q in mantle cell lymphoma.

Flordal Thelander E; Ichimura K; Collins VP; Walsh SH; Barbany G; Hagberg A; Laurell A; Rosenquist R; Larsson C; Lagercrantz S
Article: MOLECULAR VISION. 2007;13:1154-1160

Two Chinese families with pulverulent congenital cataracts and deltaG91 CRYBA1 mutations.

Lu S; Zhao C; Jiao H; Kere J; Tang X; Zhao F; Zhang X; Zhao K; Larsson C
Article: ENDOCRINE-RELATED CANCER. 2007;14(2):501-512

Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification.

Juhlin CC; Villablanca A; Sandelin K; Haglund F; Nordenström J; Forsberg L; Bränström R; Obara T; Arnold A; Larsson C; Höög A
Article: ENDOCRINE-RELATED CANCER. 2007;14(2):381-391

A PCR-based expression signature of malignancy in follicular thyroid tumors.

Foukakis T; Gusnanto A; Au AYM; Höög A; Lui W-O; Larsson C; Wallin G; Zedenius J
Article: THYROID. 2007;17(4):289-301

Molecular cytogenetic profiles of novel and established human anaplastic thyroid carcinoma models.

Lee J-J; Foukakis T; Hashemi J; Grimelius L; Heldin N-E; Wallin G; Rudduck C; Lui W-O; Höög A; Larsson C
Article: ENDOCRINE-RELATED CANCER. 2007;14(1):125-134

The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma.

Geli J; Kiss N; Lanner F; Foukakis T; Natalishvili N; Larsson O; Kogner P; Höög A; Clark GJ; Ekström TJ; Bäckdahl M; Farnebo F; Larsson C
Article: MODERN PATHOLOGY. 2007;20(1):63-75

Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma.

Berglund M; Enblad G; Thunberg U; Amini R-M; Sundström C; Roos G; Erlanson M; Rosenquist R; Larsson C; Lagercrantz S
Article: JOURNAL OF BIOTECHNOLOGY. 2006;126(4):582-586

Pre-fractionation of archival frozen tumours for proteomics applications.

Forsberg L; Larsson C; Sofiadis A; Lewensohn R; Höög A; Lehtiö J
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2006;29(5):1173-1182

A dog pedigree with familial medullary thyroid cancer.

Lee J-J; Larsson C; Lui W-O; Höög A; Von Euler H
Article: BRITISH JOURNAL OF CANCER. 2006;95(3):331-338

Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas.

Andersson S; Wallin K-L; Hellström A-C; Morrison LE; Hjerpe A; Auer G; Ried T; Larsson C; Heselmeyer-Haddad K
Article: EXPERIMENTAL CELL RESEARCH. 2006;312(11):1989-1995

LUMA (LUminometric Methylation Assay)--a high throughput method to the analysis of genomic DNA methylation.

Karimi M; Johansson S; Stach D; Corcoran M; Grandér D; Schalling M; Bakalkin G; Lyko F; Larsson C; Ekström TJ
Article: HUMAN GENETICS. 2006;119(6):617-623

A novel locus (RP33) for autosomal dominant retinitis pigmentosa mapping to chromosomal region 2cen-q12.1.

Zhao C; Lu S; Zhou X; Zhang X; Zhao K; Larsson C
Article: LANCET ONCOLOGY. 2006;7(7):605-607

A 10-year-old girl with bifocal synovial sarcoma.

Weng W-H; Claviez A; Krams M; Hashemi J; Larsson O; Larsson C; Suttorp M
Article: ENDOCRINE-RELATED CANCER. 2006;13(2):509-523

Loss of parafibromin expression in a subset of parathyroid adenomas.

Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
Article: ONCOGENE. 2006;25(22):3186-3195

The insulin-like growth factor-1 receptor inhibitor PPP produces only very limited resistance in tumor cells exposed to long-term selection.

Vasilcanu D; Weng W-H; Girnita A; Lui W-O; Vasilcanu R; Axelson M; Larsson O; Larsson C; Girnita L
Article: EJSO. 2006;32(3):345-352

Predictors of outcome in patients with papillary thyroid carcinoma.

Kjellman P; Zedenius J; Lundell G; Bäckdahl M; Farnebo L-O; Hamberger B; Larsson C; Wallin G
Article: INTERNATIONAL JOURNAL OF CANCER. 2006;118(5):1159-1164

Detailed assessment of chromosome 22 aberrations in sporadic pheochromocytoma using array-CGH.

Jarbo C; Buckley PG; Piotrowski A; Mantripragada KK; Benetkiewicz M; Diaz de Ståhl T; Langford CF; Gregory SG; Dralle H; Gimm O; Bäckdahl M; Geli J; Larsson C; Westin G; Akerström G; Dumanski JP
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2006;91(3):1143-1149

The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusion.

Foukakis T; Au AYM; Wallin G; Geli J; Forsberg L; Clifton-Bligh R; Robinson BG; Lui W-O; Zedenius J; Larsson C
Article: INTERNATIONAL JOURNAL OF RADIATION BIOLOGY. 2006;82(2):87-96

Evaluation of spectral karyotyping (SKY) in biodosimetry for the triage situation following gamma irradiation.

Szeles A; Joussineau S; Lewensohn R; Lagercrantz S; Larsson C
Article: PROSTATE. 2006;66(2):157-172

Cytogenetic and expression profiles associated with transformation to androgen-resistant prostate cancer.

Pang S-T; Weng W-H; Flores-Morales A; Johansson B; Pourian MR; Nilsson P; Pousette A; Larsson C; Norstedt G
Article: TUMOR BIOLOGY. 2006;27(4):211-220

Molecular markers for discrimination of benign and malignant follicular thyroid tumors.

Fryknäs M; Wickenberg-Bolin U; Göransson H; Gustafsson MG; Foukakis T; Lee J-J; Landegren U; Höög A; Larsson C; Grimelius L; Wallin G; Pettersson U; Isaksson A
Article: INTERNAL MEDICINE. 2006;45(2):81-86

Multiple endocrine neoplasia type I and Cushing's syndrome due to an aggressive ACTH producing thymic carcinoid.

Takagi J; Otake K; Morishita M; Kato H; Nakao N; Yoshikawa K; Ikeda H; Hirooka Y; Hattori Y; Larsson C; Nogimori T
Article: ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY. 2006;101(2):214-220

Dental findings in a family with hyperparathyroidism-jaw tumor syndrome and a novel HRPT2 gene mutation

Aldred MJ; Talacko AA; Savarirayan R; Murdolo V; Mills AE; Radden BG; Alimov A; Villablanca A; Larsson C
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2005;13(12):1261-1267

Novel and de novo mutations of the IRF6 gene detected in patients with Van der Woude or popliteal pterygium syndrome.

Peyrard-Janvid M; Pegelow M; Koillinen H; Larsson C; Fransson I; Rautio J; Hukki J; Larson O; Karsten AL-A; Kere J
Article: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES. 2005;113(9):516-521

Lack of mutations in the TSHr and Gsalpha genes in TSHr antibody negative Graves' disease.

Elgadi A; Frisk T; Larsson C; Wallin G; Höög A; Zedenius J; Norgren S
Article: CLINICAL CANCER RESEARCH. 2005;11(17):6198-6204

Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas.

Weng W-H; Ahlén J; Aström K; Lui W-O; Larsson C
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2005;13(8):970-977

Loss of ZDHHC15 expression in a woman with a balanced translocation t(X;15)(q13.3;cen) and severe mental retardation.

Mansouri MR; Marklund L; Gustavsson P; Davey E; Carlsson B; Larsson C; White I; Gustavson K-H; Dahl N
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2005;26(5):1385-1391

Deletions and altered expression of the RIZ1 tumour suppressor gene in 1p36 in pheochromocytomas and abdominal paragangliomas.

Geli J; Nord B; Frisk T; Edström Elder E; Ekström TJ; Carling T; Bäckdahl M; Larsson C
Article: ANTICANCER RESEARCH. 2005;25(2A):683-691

Immunophenotypic and molecular cytogenetic features of the cell line UP-LN1 established from a lymph node metastasis of a poorly-differentiated carcinoma.

Chang CT-R; Weng W-H; Chou AS-B; Chuang C-K; Porwit-McDonald A; Pang S-T; Larsson C; Liao S-K
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2005;152(3):459-470

Distinction in gene expression profiles demonstrated in parathyroid adenomas by high-density oligoarray technology.

Forsberg L; Björck E; Hashemi J; Zedenius J; Höög A; Farnebo L-O; Reimers M; Larsson C
Article: MODERN PATHOLOGY. 2005;18(3):331-339

Mantle cell lymphomas with clonal immunoglobulin V(H)3-21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin V(H) genes.

Thelander EF; Walsh SH; Thorsélius M; Laurell A; Landgren O; Larsson C; Rosenquist R; Lagercrantz S
Article: JOURNAL OF SURGICAL ONCOLOGY. 2005;89(3):193-201

Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor.

Elder EE; Elder G; Larsson C
Article: ONCOGENE. 2005;24(8):1467-1476

Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPAR(gamma) fusion oncogene.

Lui W-O; Foukakis T; Lidén J; Thoppe SR; Dwight T; Höög A; Zedenius J; Wallin G; Reimers M; Larsson C
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2005;26(1):141-149

Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors.

Foukakis T; Thoppe SR; Lagercrantz S; Dwight T; Weng W-H; Svensson A; Höög A; Zedenius J; Wallin G; Lui W-O; Larsson C
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2005;26(1):5-16

Loss of chromosome 13q is a frequently acquired event in genetic progression of soft tissue sarcomas in the abdominal cavity.

Weng W-H; Lerner M; Grandér D; Ahlén J; Villablanca A; Pang S-T; Wejde J; Lui W-O; Larsson C
Article: CLINICAL CANCER RESEARCH. 2005;11(1):206-216

Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.

Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng W-H; Girnita L; Larsson O; Larsson C
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2004;25(4):955-960

Molecular cytogenetic characterization shows higher genetic homogeneity in conventional renal cell carcinoma compared to other kidney cancers.

Alimov A; Sundelin B; Bergerheim U; Pavlenko M; Pisa P; Zetterberg A; Larsson C; Lagercrantz S
Article: GENES CHROMOSOMES & CANCER. 2004;41(2):133-144

Spontaneously immortalized human T lymphocytes develop gain of chromosomal region 2p13-24 as an early and common genetic event.

Siwicki JK; Berglund M; Rygier J; Pienkowska-Grela B; Grygalewicz B; Degerman S; Golovleva I; Chrzanowska KH; Lagercrantz S; Blennow E; Roos G; Larsson C
Article: GENES CHROMOSOMES & CANCER. 2004;40(4):285-297

DLEU2 encodes an antisense RNA for the putative bicistronic RFP2/LEU5 gene in humans and mouse.

Corcoran MM; Hammarsund M; Zhu C; Lerner M; Kapanadze B; Wilson B; Larsson C; Forsberg L; Ibbotson RE; Einhorn S; Oscier DG; Grandér D; Sangfelt O
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2004;25(1):179-185

Loss of 14q31-q32.2 in renal cell carcinoma is associated with high malignancy grade and poor survival.

Alimov A; Sundelin B; Wang N; Larsson C; Bergerheim U
Article: CANCER GENETICS. 2004;150(1):27-32

Characterization of large chromosome markers in a malignant fibrous histiocytoma by spectral karyotyping, comparative genomic hybridization (CGH), and array CGH.

Weng W-H; Wejde J; Ahlén J; Pang S-T; Lui W-O; Larsson C
Article: JOURNAL OF MEDICAL GENETICS. 2004;41(3):e32-32

Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP).

Villablanca A; Calender A; Forsberg L; Höög A; Cheng J-D; Petillo D; Bauters C; Kahnoski K; Ebeling T; Salmela P; Richardson A-L; Delbridge L; Meyrier A; Proye C; Carpten JD; Teh BT; Robinson BG; Larsson C
Article: CYTOGENETIC AND GENOME RESEARCH. 2004;106(1):28-32

Analysis of the cytogenetic stability of the human embryonal kidney cell line 293 by cytogenetic and STR profiling approaches.

Bylund L; Kytölä S; Lui W-O; Larsson C; Weber G
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2003;278(50):49685-49690

High extracellular Ca2+ hyperpolarizes human parathyroid cells via Ca(2+)-activated K+ channels.

Välimäki S; Höög A; Larsson C; Farnebo L-O; Bränström R
Article: CANCER CELL. 2003;4(5):405-413

The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas.

Chen J; Lui W-O; Vos MD; Clark GJ; Takahashi M; Schoumans J; Khoo SK; Petillo D; Lavery T; Sugimura J; Astuti D; Zhang C; Kagawa S; Maher ER; Larsson C; Alberts AS; Kanayama H-O; Teh BT
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2003;349(18):1722-1729

Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.

Shattuck TM; Välimäki S; Obara T; Gaz RD; Clark OH; Shoback D; Wierman ME; Tojo K; Robbins CM; Carpten JD; Farnebo L-O; Larsson C; Arnold A
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2003;88(9):4440-4445

Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors.

Dwight T; Thoppe SR; Foukakis T; Lui WO; Wallin G; Höög A; Frisk T; Larsson C; Zedenius J
Article: ONCOLOGY REPORTS. 2003;10(5):1641-1645

Evaluation of immunohistochemical parameters as prognostic markers in malignant fibrous histiocytoma.

Ahlén J; Weng WW-H; Brosjö O; Von Rosen A; Larsson O; Larsson C
Article: BRITISH JOURNAL OF CANCER. 2003;89(4):720-726

Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease-free survival and a low risk of developing distant metastasis.

Weng W-H; Ahlén J; Lui W-O; Brosjö O; Pang S-T; Von Rosen A; Auer G; Larsson O; Larsson C
Article: CLINICAL ENDOCRINOLOGY. 2003;59(1):129-135

Multiple endocrine neoplasia type 1 (MEN1): genetic and clinical analysis in the Southern Chinese.

Tso AWK; Rong R; Lo CY; Tan KCB; Tiu SC; Wat NMS; Xu JY; Villablanca A; Larsson C; Teh BT; Lam KSL
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2003;22(5):1003-1007

Mutation analysis of the BRG1 gene in prostate cancer clinical samples.

Valdman A; Nordenskjöld A; Fang X; Naito A; Al-Shukri S; Larsson C; Ekman P; Li C
Article: ONCOGENE. 2003;22(14):2215-2222

Characteristic sequence motifs located at the genomic breakpoints of the translocation t(X;18) in synovial sarcomas.

Wei Y; Sun M; Nilsson G; Dwight T; Xie Y; Wang J; Hou Y; Larsson O; Larsson C; Zhu X
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2003;11(4):529-533

Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene.

Li C; Grönberg H; Matsuyama H; Weber G; Nordenskjöld M; Naito K; Bergh A; Bergerheim U; Damber J-E; Larsson C; Ekman P
Article: THYROID. 2003;13(4):371-380

MIB-1 index in thyroid tumors: a predictor of the clinical course in papillary thyroid carcinoma.

Kjellman P; Wallin G; Höög A; Auer G; Larsson C; Zedenius J
Article: MODERN PATHOLOGY. 2003;16(3):246-255

KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.

Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
Article: CANCER GENETICS. 2003;141(1):43-48

Molecular cytogenetic characterization of four commonly used cell lines derived from Hodgkin lymphoma.

Berglund M; Flordal E; Gullander J; Lui W-O; Larsson C; Lagercrantz S; Enblad G
Article: NATURE GENETICS. 2002;32(4):676-680

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome.

Carpten JD; Robbins CM; Villablanca A; Forsberg L; Presciuttini S; Bailey-Wilson J; Simonds WF; Gillanders EM; Kennedy AM; Chen JD; Agarwal SK; Sood R; Jones MP; Moses TY; Haven C; Petillo D; Leotlela PD; Harding B; Cameron D; Pannett AA; Höög A; Heath H; James-Newton LA; Robinson B; Zarbo RJ; Cavaco BM; Wassif W; Perrier ND; Rosen IB; Kristoffersson U; Turnpenny PD; Farnebo L-O; Besser GM; Jackson CE; Morreau H; Trent JM; Thakker RV; Marx SJ; Teh BT; Larsson C; Hobbs MR
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2002;21(6):1197-1204

Identifying cancer-related genes in nasopharyngeal carcinoma cell lines using DNA and mRNA expression profiling analyses.

Guo X; Lui W-O; Qian C-N; Chen J-D; Gray SG; Rhodes D; Haab B; Stanbridge E; Wang H; Hong M-H; Min H-Q; Larsson C; Teh BT
Article: CANCER GENETICS. 2002;139(1):38-43

Clonal development of a blastoid mantle cell lymphoma studied with comparative genomic hybridization.

Flordal E; Berglund M; Rosenquist R; Erlanson M; Enblad G; Roos G; Larsson C; Lagercrantz S
Article: AMERICAN JOURNAL OF PATHOLOGY. 2002;161(4):1299-1306

Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidism.

Dwight T; Nelson AE; Theodosopoulos G; Richardson AL; Learoyd DL; Philips J; Delbridge L; Zedenius J; Teh BT; Larsson C; Marsh DJ; Robinson BG
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2002;21(4):727-735

Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas.

Välimäki S; Forsberg L; Farnebo L-O; Larsson C
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2002;147(3):313-322

Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism.

Villablanca A; Wassif WS; Smith T; Höög A; Vierimaa O; Kassem M; Dwight T; Forsberg L; Du Q; Learoyd D; Jones K; Stranks S; Juhlin C; Teh BT; Carling T; Robinson B; Larsson C
Article: GENES CHROMOSOMES & CANCER. 2002;35(1):74-80

Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.

Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C
Article: MODERN PATHOLOGY. 2002;15(8):807-816

Chromosomal imbalances in diffuse large B-cell lymphoma detected by comparative genomic hybridization.

Berglund M; Enblad G; Flordal E; Lui W-O; Backlin C; Thunberg U; Sundström C; Roos G; Allander SV; Erlanson M; Rosenquist R; Larsson C; Lagercrantz S
Article: GENES CHROMOSOMES & CANCER. 2002;34(3):325-332

Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell carcinomas, pheochromocytomas, and abdominal paragangliomas.

Kytölä S; Nord B; Elder EE; Carling T; Kjellman M; Cedermark B; Juhlin C; Höög A; Isola J; Larsson C
Article: ONCOGENE. 2002;21(26):4181-4190

Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas.

Yang K; Lui W-O; Xie Y; Zhang A; Skytting B; Mandahl N; Larsson C; Larsson O
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2002;20(6):1161-1165

Aberrations of centrosomes in adrenocortical tumors.

Roshani L; Fujioka K; Auer G; Kjellman M; Lagercrantz S; Larsson C
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2002;146(5):619-627

Genetic analysis of lithium-associated parathyroid tumors.

Dwight T; Kytölä S; Teh BT; Theodosopoulos G; Richardson AL; Philips J; Twigg S; Delbridge L; Marsh DJ; Nelson AE; Larsson C; Robinson BG
Article: BMC CANCER. 2002;2:5

Chromosomal aberrations in benign and malignant bilharzia-associated bladder lesions analyzed by comparative genomic hybridization.

Fadl-Elmula I; Kytola S; Leithy MEL; Abdel-Hameed M; Mandahl N; Elagib A; Ibrahim M; Larsson C; Heim S
Article: ONCOGENE. 2002;21(7):1117-1122

Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndrome.

Lui WO; Chen J; Gläsker S; Bender BU; Madura C; Khoo SK; Kort E; Larsson C; Neumann HPH; Teh BT
Article: CLINICAL ENDOCRINOLOGY. 2002;56(2):261-269

Genetic and clinical characterization of sporadic cystic parathyroid tumours.

Villablanca A; Farnebo F; Teh BT; Farnebo L-O; Höög A; Larsson C
Article: MAMMALIAN GENOME. 2002;13(1):20-23

Characterization of a putative murine mitochondrial transporter homology of hMRS3/4.

Li F-Y; Leibiger B; Leibiger I; Larsson C
Article: CLINICAL ENDOCRINOLOGY. 2002;56(2):259-267

Genetic and clinical characterization of sporadic cystic parathyroid tumours

Villablanca A; Farnebo F; Teh BT; Farnebo LO; Höög A; Larsson C
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2001;8(6):681-689

Differential expression of multiple alternative spliceforms of the Men1 tumor suppressor gene in mouse.

Forsberg L; Zablewska B; Piehl F; Weber G; Lagercrantz S; Gaudray P; Höög C; Larsson C
Article: KIDNEY INTERNATIONAL. 2001;60(5):1666-1675

Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.

Välimäki S; Farnebo F; Forsberg L; Larsson C; Farnebo LO
Article: EXPERIMENTAL CELL RESEARCH. 2001;270(1):88-95

Methylation changes in the human IGF2 p3 promoter parallel IGF2 expression in the primary tumor, established cell line, and xenograft of a human hepatoblastoma.

Eriksson T; Frisk T; Gray SG; von Schweinitz D; Pietsch T; Larsson C; Sandstedt B; Ekström TJ
Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2001;9(10):747-752

Mapping of the second locus for the Van der Woude syndrome to chromosome 1p34.

Koillinen H; Wong FK; Rautio J; Ollikainen V; Karsten A; Larson O; Teh BT; Huggare J; Lahermo P; Larsson C; Kere J
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2001;145(4):415-420

Homozygous inactivation of the MEN1 gene as a specific somatic event in a case of secondary hyperparathyroidism.

Forsberg L; Villablanca A; Välimäki S; Farnebo F; Farnebo LO; Lagercrantz S; Larsson C
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2001;19(3):451-457

High level amplification of 1p32-33 and 2p22-24 in small cell lung carcinomas.

Lui WO; Tanenbaum DM; Larsson C
Article: GENES CHROMOSOMES & CANCER. 2001;32(1):43-49

Gain of 1q and loss of 9q21.3-q32 are associated with a less favorable prognosis in papillary thyroid carcinoma.

Kjellman P; Lagercrantz S; Höög A; Wallin G; Larsson C; Zedenius J
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2001;286(2):426-431

Menin interacts directly with the homeobox-containing protein Pem.

Lemmens IH; Forsberg L; Pannett AA; Meyen E; Piehl F; Turner JJ; Van de Ven WJ; Thakker RV; Larsson C; Kas K
Article: NATURE GENETICS. 2001;28(3):223-231

Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria.

Spelbrink JN; Li FY; Tiranti V; Nikali K; Yuan QP; Tariq M; Wanrooij S; Garrido N; Comi G; Morandi L; Santoro L; Toscano A; Fabrizi GM; Somer H; Croxen R; Beeson D; Poulton J; Suomalainen A; Jacobs HT; Zeviani M; Larsson C
Article: WORLD JOURNAL OF SURGERY. 2001;25(7):948-956

Genetic background of adrenocortical tumor development.

Kjellman M; Larsson C; Bäckdahl M
Article: INTERNATIONAL JOURNAL OF CANCER. 2001;92(6):824-831

Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis.

Fadl-Elmula I; Kytölä S; Pan Y; Lui WO; Derienzo G; Forsberg L; Mandahl N; Gorunova L; Bergerheim US; Heim S; Larsson C
Article: CANCER GENETICS. 2001;127(2):128-133

A highly aggressive primitive mesenchymal tumor with a translocation (1;19)(q12;q13.2).

Lui W; Wejde J; Tani E; Brosjö O; Kytölä S; Larsson C
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2001;18(6):1219-1225

CGH alterations in medullary thyroid carcinomas in relation to the RET M918T mutation and clinical outcome.

Frisk T; Zedenius J; Lundberg J; Wallin G; Kytölä S; Larsson C
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2001;66(5):297-304

Identification of numerical and structural chromosome aberrations in 15 high hyperdiploid childhood acute lymphoblastic leukemias using spectral karyotyping.

Nordgren A; Farnebo F; Johansson B; Holmgren G; Forestier E; Larsson C; Söderhäll S; Nordenskjöld M; Blennow E
Article: AMERICAN JOURNAL OF PATHOLOGY. 2001;158(5):1803-1808

Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids.

Kytölä S; Höög A; Nord B; Cedermark B; Frisk T; Larsson C; Kjellman M
Article: FEBS LETTERS. 2001;494(1-2):79-84

Characterization of a novel human putative mitochondrial transporter homologous to the yeast mitochondrial RNA splicing proteins 3 and 4.

Li FY; Nikali K; Gregan J; Leibiger I; Leibiger B; Schweyen R; Larsson C; Suomalainen A
Article: CANCER GENETICS. 2001;126(1):1-7

Aberrations of chromosome 8 in 16 breast cancer cell lines by comparative genomic hybridization, fluorescence in situ hybridization, and spectral karyotyping.

Rummukainen J; Kytölä S; Karhu R; Farnebo F; Larsson C; Isola JJ
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2001;7(3):289-294

Dominantly inherited familial myasthenia gravis as a separate genetic entity without involvement of defined candidate gene loci.

Li F; Szobor A; Croxen R; Anselmo V; Yuan QP; Lindblad K; Schalling M; Komoly S; Beeson D; Larsson C
Article: JOURNAL OF MEDICAL GENETICS. 2001;38(3):165-170

Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma.

Kanayama H; Lui WO; Takahashi M; Naroda T; Kedra D; Wong FK; Kuroki Y; Nakahori Y; Larsson C; Kagawa S; Teh BT
Article: GENES CHROMOSOMES & CANCER. 2001;30(2):187-195

5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines.

Pan Y; Lui WO; Nupponen N; Larsson C; Isola J; Visakorpi T; Bergerheim US; Kytölä S
Article: GENE. 2001;262(1-2):51-59

Characterisation of the human APC1, the largest subunit of the anaphase-promoting complex.

Jörgensen PM; Gräslund S; Betz R; Ståhl S; Larsson C; Höög C
Article: SARCOMA. 2001;5(3):143-149

Malignant Fibrous Histiocytoma, Aggressive Fibromatosis and Benign Fibrous Tumors Express mRNA for the Metalloproteinase Inducer EMMPRIN and the Metalloproteinases MMP-2 and MT1-MMP.

Ahlén J; Enberg U; Larsson C; Larsson O; Frisk T; Brosjö O; Rosen A; Bäckdahl M
Article: CYTOGENETIC AND GENOME RESEARCH. 2001;92(1-2):89-96

Chromosomal distribution, localization and expression of the human endogenous retrovirus ERV9.

Svensson AC; Raudsepp T; Larsson C; Di Cristofano A; Chowdhary B; La Mantia G; Rask L; Andersson G
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2000;6(4):469-474

Expression analysis of RET and the GDNF/GFRalpha-1 and NTN/GFRalpha-2 ligand complexes in pheochromocytomas and paragangliomas.

Edström E; Frisk T; Farnebo F; Höög A; Bäckdahl M; Larsson C
Article: BRITISH JOURNAL OF CANCER. 2000;83(8):1020-1025

Comparative genomic hybridization reveals population-based genetic alterations in hepatoblastomas.

Gray SG; Kytölä S; Matsunaga T; Larsson C; Ekström TJ
Article: NATURE BIOTECHNOLOGY. 2000;18(9):1001-1005

Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays.

Lindblad-Toh K; Tanenbaum DM; Daly MJ; Winchester E; Lui WO; Villapakkam A; Stanton SE; Larsson C; Hudson TJ; Johnson BE; Lander ES; Meyerson M
Article: INTERNATIONAL JOURNAL OF CANCER. 2000;87(4):463-467

Malignant melanoma in patients with multiple endocrine neoplasia type 1 and involvement of the MEN1 gene in sporadic melanoma.

Nord B; Platz A; Smoczynski K; Kytölä S; Robertson G; Calender A; Murat A; Weintraub D; Burgess J; Edwards M; Skogseid B; Owen D; Lassam N; Hogg D; Larsson C; Teh BT
Article: AMERICAN JOURNAL OF PATHOLOGY. 2000;157(2):579-586

Patterns of chromosomal imbalances in parathyroid carcinomas.

Kytölä S; Farnebo F; Obara T; Isola J; Grimelius L; Farnebo LO; Sandelin K; Larsson C
Article: CLINICAL ENDOCRINOLOGY. 2000;53(2):205-211

Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1 (MEN 1).

Burgess JR; Nord B; David R; Greenaway TM; Parameswaran V; Larsson C; Shepherd JJ; Teh BT
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2000;6(2):161-169

Expression of genes involved with cell cycle control, cell growth and chromatin modification are altered in hepatoblastomas.

Gray SG; Hartmann W; Eriksson T; Ekstrom C; Holm S; Kytola S; von Schweinitz D; Pietsch T; Larsson C; Kogner P; Sandstedt B; Ekstrom TJ
Article: CLINICAL ENDOCRINOLOGY. 2000;53(1):85-92

Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13.

Dwight T; Twigg S; Delbridge L; Wong FK; Farnebo F; Richardson AL; Nelson A; Zedenius J; Philips J; Larsson C; Teh BT; Robinson B
Article: CLEFT PALATE CRANIOFACIAL JOURNAL. 2000;37(4):357-362

Linkage analysis of candidate regions in Swedish nonsyndromic cleft lip with or without cleft palate families.

Wong FK; Hagberg C; Karsten A; Larson O; Gustavsson M; Huggare J; Larsson C; Teh BT; Linder-Aronson S
Article: GENES CHROMOSOMES & CANCER. 2000;28(3):308-317

Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping.

Kytölä S; Rummukainen J; Nordgren A; Karhu R; Farnebo F; Isola J; Larsson C
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2000;6(1):73-81

Characterization of the human peroxisome proliferator activated receptor delta gene and its expression.

Skogsberg J; Kannisto K; Roshani L; Gagne E; Hamsten A; Larsson C; Ehrenborg E
Article: CANCER GENETICS. 2000;119(2):109-112

Balanced translocation (3;7)(p25;q34): another mechanism of tumorigenesis in follicular thyroid carcinoma?

Lui WO; Kytölä S; Anfalk L; Larsson C; Farnebo LO
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2000;142(6):643-649

Expression of RET and its ligand complexes, GDNF/GFRalpha-1 and NTN/GFRalpha-2, in medullary thyroid carcinomas.

Frisk T; Farnebo F; Zedenius J; Grimelius L; Höög A; Wallin G; Larsson C
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2000;5(5):485-492

New chromosomal breakpoints in non-Hodgkin's lymphomas revealed by spectral karyotyping and G-banding.

Nordgren A; Sørensen AG; Tinggaard-Pedersen N; Blennow E; Larsson C; Lagercrantz S
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2000;85(4):1449-1454

A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome.

Haven CJ; Wong FK; van Dam EW; van der Juijt R; van Asperen C; Jansen J; Rosenberg C; de Wit M; Roijers J; Hoppener J; Lips CJ; Larsson C; Teh BT; Morreau H
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2000;5(3):235-240

Spectral karyotyping and chromosome banding studies of primary breast carcinomas and their lymph node metastases.

Adeyinka A; Kytola S; Mertens F; Pandis N; Larsson C
Article: AMERICAN JOURNAL OF PATHOLOGY. 2000;156(2):651-659

Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology.

Edström E; Mahlamäki E; Nord B; Kjellman M; Karhu R; Höög A; Goncharov N; Teh BT; Bäckdahl M; Larsson C
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2000;85(1):165-167

Familial isolated hyperparathyroidism as a variant of multiple endocrine neoplasia type 1 in a large Danish pedigree.

Kassem M; Kruse TA; Wong FK; Larsson C; Teh BT
Article: MAMMALIAN GENOME. 2000;11(1):78-80

Molecular characterization of human and murine C11orf5, a new member of the FAUNA gene cluster.

Lemmens IH; Farnebo F; Piehl F; Merregaert J; Van de Ven WJ; Larsson C; Kas K
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2000;5(1):33-41

Modulating IGFBP-3 expression by trichostatin A: potential therapeutic role in the treatment of hepatocellular carcinoma.

Gray SG; Kytola S; Lui WO; Larsson C; Ekstrom TJ
Article: HEMATOLOGY JOURNAL. 2000;1(2):95-101

Detailed characterization of a complex karyotype in a patient with primary plasma cell leukaemia using multicolour spectral karyotyping and micro-FISH.

Nordgren A; Farnebo F; Björkholm M; Sahlén S; Porwit-MacDonald A; Osby E; Kytölä S; Larsson C; Nordenskjöld M; Blennow E
Article: NEUROLOGY. 1999;53(6):1265-1271

Mapping of autosomal dominant progressive external ophthalmoplegia to a 7-cM critical region on 10q24.

Li FY; Tariq M; Croxen R; Morten K; Squier W; Newsom-Davis J; Beeson D; Larsson C
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1999;84(10):3775-3780

Alternative genetic pathways in parathyroid tumorigenesis.

Farnebo F; Kytölä S; Teh BT; Dwight T; Wong FK; Höög A; Elvius M; Wassif WS; Thompson NW; Farnebo LO; Sandelin K; Larsson C
Article: GENES CHROMOSOMES & CANCER. 1999;26(1):35-39

Sporadic follicular thyroid tumors show loss of a 200-kb region in 11q13 without evidence for mutations in the MEN1 gene.

Nord B; Larsson C; Wong FK; Wallin G; Teh BT; Zedenius J
Article: GENES CHROMOSOMES & CANCER. 1999;25(4):349-353

Low frequency of numerical chromosomal aberrations in follicular thyroid tumors detected by comparative genomic hybridization.

Frisk T; Kytölä S; Wallin G; Zedenius J; Larsson C
Article: FEBS LETTERS. 1999;450(3):210-216

Suppression of the neoplastic phenotype by transfection of phospholipase C beta 3 to neuroendocrine tumor cells.

Stålberg P; Wang S; Larsson C; Weber G; Oberg K; Gobl A; Skogseid B
Article: MAMMALIAN GENOME. 1999;10(4):376-380

Characterization and chromosomal localization of the human insulin-like growth factor-binding protein 6 gene.

Ehrenborg E; Zazzi H; Lagercrantz S; Granqvist M; Hillerbrand U; Allander SV; Larsson C; Luthman H
Article: ACTA ODONTOLOGICA SCANDINAVICA. 1999;57(2):72-76

Clinical and genetic studies of Van der Woude syndrome in Sweden.

Wong FK; Karsten A; Larson O; Huggare J; Hagberg C; Larsson C; Teh BT; Linder-Aronson S
Article: WORLD JOURNAL OF SURGERY. 1999;23(3):237-242

Gelatinase A and membrane-type 1 matrix metalloproteinase mRNA: expressed in adrenocortical cancers but not in adenomas.

Kjellman M; Enberg U; Höög A; Larsson C; Holst M; Farnebo LO; Sato H; Bäckdahl M
Article: GENES CHROMOSOMES & CANCER. 1999;24(3):175-182

Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer.

Li C; Berx G; Larsson C; Auer G; Aspenblad U; Pan Y; Sundelin B; Ekman P; Nordenskjöld M; van Roy F; Bergerheim US
Article: CLINICAL ENDOCRINOLOGY. 1999;50(3):343-346

No overrepresentation of congenital adrenal hyperplasia in patients with adrenocortical tumours.

Kjellman M; Holst M; Bäckdahl M; Larsson C; Farnebo LO; Wedell A
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1999;84(2):730-735

Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16.

Kjellman M; Roshani L; Teh BT; Kallioniemi OP; Höög A; Gray S; Farnebo LO; Holst M; Bäckdahl M; Larsson C
Article: CLINICAL ENDOCRINOLOGY. 1999;50(2):191-196

Genetic studies of a family with hereditary hyperparathyroidism-jaw tumour syndrome.

Wassif WS; Farnebo F; Teh BT; Moniz CF; Li FY; Harrison JD; Peters TJ; Larsson C; Harris P
Article: WORLD JOURNAL OF SURGERY. 1999;23(1):68-74

Evaluation of retinoblastoma and Ki-67 immunostaining as diagnostic markers of benign and malignant parathyroid disease.

Farnebo F; Auer G; Farnebo LO; Teh BT; Twigg S; Aspenblad U; Thompson NW; Grimelius L; Larsson C; Sandelin K
Article: CYTOGENETIC AND GENOME RESEARCH. 1999;87(3-4):225-232

Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping.

Pan Y; Kytölä S; Farnebo F; Wang N; Lui WO; Nupponen N; Isola J; Visakorpi T; Bergerheim US; Larsson C
Article: FEBS LETTERS. 1998;441(2):261-265

Targeted disruption of the mouse phospholipase C beta3 gene results in early embryonic lethality.

Wang S; Gebre-Medhin S; Betsholtz C; Stålberg P; Zhou Y; Larsson C; Weber G; Feinstein R; Oberg K; Gobl A; Skogseid B
Article: ONCOGENE. 1998;17(19):2485-2493

Characterization of the mouse Men1 gene and its expression during development.

Stewart C; Parente F; Piehl F; Farnebo F; Quincey D; Silins G; Bergman L; Carle GF; Lemmens I; Grimmond S; Xian CZ; Khodei S; Teh BT; Lagercrantz J; Siggers P; Calender A; Van de Vem V; Kas K; Weber G; Hayward N; Gaudray P; Larsson C
Article: GENOMICS. 1998;52(2):245-246

Human histone deacetylase 2, HDAC2 (Human RPD3), is localized to 6q21 by radiation hybrid mapping.

Betz R; Gray SG; Ekström C; Larsson C; Ekström TJ
Article: GENOMICS. 1998;52(2):201-204

Restriction map of a YAC and cosmid contig encompassing the oculopharyngeal muscular dystrophy candidate region on chromosome 14q11.2-q13.

Xie YG; Rochefort D; Brais B; Howard H; Han FY; Gou LP; Maciel P; The BT; Larsson C; Rouleau GA
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1998;83(8):2627-2630

Alterations of the MEN1 gene in sporadic parathyroid tumors.

Farnebo F; Teh BT; Kytölä S; Svensson A; Phelan C; Sandelin K; Thompson NW; Höög A; Weber G; Farnebo LO; Larsson C
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1998;83(8):2621-2626

Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism.

Teh BT; Kytölä S; Farnebo F; Bergman L; Wong FK; Weber G; Hayward N; Larsson C; Skogseid B; Beckers A; Phelan C; Edwards M; Epstein M; Alford F; Hurley D; Grimmond S; Silins G; Walters M; Stewart C; Cardinal J; Khodaei S; Parente F; Tranebjaerg L; Jorde R; Salmela P
Article: MAMMALIAN GENOME. 1998;9(8):660-665

Expression and chromosomal localization of the Requiem gene.

Gabig TG; Crean CD; Klenk A; Long H; Copeland NG; Gilbert DJ; Jenkins NA; Quincey D; Parente F; Lespinasse F; Carle GF; Gaudray P; Zhang CX; Calender A; Hoeppener J; Kas K; Thakker RV; Farnebo F; Teh BT; Larsson C; Piehl F; Lagercrantz J; Khodaei S; Carson E; Weber G
Article: ANNALS OF SURGERY. 1998;228(1):99-105

Thymic carcinoids in multiple endocrine neoplasia type 1.

Teh BT; Zedenius J; Kytölä S; Skogseid B; Trotter J; Choplin H; Twigg S; Farnebo F; Giraud S; Cameron D; Robinson B; Calender A; Larsson C; Salmela P
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1998;247(2):357-360

Expression of the BCL6 gene in the pre- and postnatal mouse.

Bajalica-Lagercrantz S; Piehl F; Farnebo F; Larsson C; Lagercrantz J
Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 1998;1398(2):157-163

A comparative study of the expression patterns for vegf, vegf-b/vrf and vegf-c in the developing and adult mouse.

Lagercrantz J; Farnebo F; Larsson C; Tvrdik T; Weber G; Piehl F
Article: GENOMICS. 1998;50(2):251-259

A putative human zinc-finger gene (ZFPL1) on 11q13, highly conserved in the mouse and expressed in exocrine pancreas. The European Consortium on MEN 1.

Höppener JW; De Wit MJ; Simarro-Doorten AY; Roijers JF; van Herrewaarden HM; Lips CJ; Parente F; Quincey D; Gaudray P; Khodaei S; Weber G; Teh B; Farnebo F; Larsson C; Zhang CX; Calender A; Pannett AA; Forbes SA; Bassett JH; Thakker RV; Lemmens I; Van de Ven WJ; Kas K
Article: GENOMICS. 1998;50(2):213-221

Cloning and characterization of ZNF189, a novel human Krüppel-like zinc finger gene localized to chromosome 9q22-q31.

Odeberg J; Røsok O; Gudmundsson GH; Ahmadian A; Roshani L; Williams C; Larsson C; Pontén F; Uhlén M; Asheim HC; Lundeberg J
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1998;83(6):2114-2120

Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families.

Teh BT; Farnebo F; Twigg S; Höög A; Kytölä S; Korpi-Hyövälti E; Wong FK; Nordenström J; Grimelius L; Sandelin K; Robinson B; Farnebo LO; Larsson C
Article: DIABETES. 1998;47(6):976-979

Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians.

Bernal D; Almind K; Yenush L; Ayoub M; Zhang Y; Rosshani L; Larsson C; Pedersen O; White MF
Article: NEUROLOGY. 1998;50(4):1067-1073

Charcot-Marie-Tooth disease and Noonan syndrome with giant proximal nerve hypertrophy.

Silburn PA; Nicholson GA; Teh BT; Blair IP; Pollard JD; Nolan PJ; Larsson C; Boyle RS
Article: MAMMALIAN GENOME. 1998;9(4):310-311

Mapping of the human Ca2+ channel beta 4 subunit to 2q22-23 and its expression in developing mouse.

Betz R; Leibiger B; Farnebo F; Lagercrantz S; Piehl F; Leibiger I; Larsson C
Article: GENES CHROMOSOMES & CANCER. 1998;21(3):260-264

Bilateral multiple renal oncocytomas and cysts associated with a constitutional translocation (8;9)(q24.1;q34.3) and a rare constitutional VHL missense substitution.

Teh BT; Blennow E; Giraud S; Sahlén S; Hii SI; Brookwell R; Brauch H; Nordenskjöld M; Larsson C; Nicol D
Article: CANCER RESEARCH. 1998;58(5):1004-1012

Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.

Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
Article: ONCOGENE. 1998;16(4):481-487

Identification of two distinct deleted regions on chromosome 13 in prostate cancer.

Li C; Larsson C; Futreal A; Lancaster J; Phelan C; Aspenblad U; Sundelin B; Liu Y; Ekman P; Auer G; Bergerheim US
Article: CANCER EPIDEMIOLOGY. 1998;22(6):544-548

A rapid method for DNA extraction from fine-needle aspiration biopsies of thyroid tumors, and subsequent RET mutation analysis.

Zedenius J; Dwight T; Robinson BG; Delbridge L; Bäckdahl M; Wallin G; Larsson C; Weber G
Article: GENOMICS. 1997;46(1):78-85

Cloning and characterization of freac-9 (FKHL17), a novel kidney-expressed human forkhead gene that maps to chromosome 1p32-p34.

Ernstsson S; Betz R; Lagercrantz S; Larsson C; Ericksson S; Cederberg A; Carlsson P; Enerbäck S
Article: CANCER RESEARCH. 1997;57(21):4710-4713

Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.

Dahia PL; Marsh DJ; Zheng Z; Zedenius J; Komminoth P; Frisk T; Wallin G; Parsons R; Longy M; Larsson C; Eng C
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1997;239(3):878-883

Novel splicing of an IGF2 polymorphic region in human adrenocortical carcinomas.

Gray SG; Kjellman M; Larsson C; Ekström TJ
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1997;82(10):3481-3486

Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism.

Farnebo F; Enberg U; Grimelius L; Bäckdahl M; Schalling M; Larsson C; Farnebo LO
Article: HUMAN GENETICS. 1997;100(5-6):657-665

The European Consortium on MEN1. Linkage disequilibrium studies in multiple endocrine neoplasia type 1 (MEN1).
Article: GENOMICS. 1997;44(3):344-346

Chromosome localization, sequence analysis, and expression pattern identify FKHL 18 as a novel human forkhead gene.

Cederberg A; Betz R; Lagercrantz S; Larsson C; Hulander M; Carlsson P; Enerbäck S
Article: GENOMICS. 1997;44(1):94-100

Construction of a 1.2-Mb sequence-ready contig of chromosome 11q13 encompassing the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.

Lemmens I; Merregaert J; Van de Ven WJ; Kas K; Zhang CX; Giraud S; Wautot V; Buisson N; De Witte K; Salandre J; Lenoir G; Calender A; Parente F; Quincey D; Courseaux A; Carle GF; Gaudray P; De Wit MJ; Lips CJ; Höppener JW; Khodaei S; Grant AL; Weber G; Kytölä S; Thakker RV
Article: HUMAN GENETICS. 1997;100(3-4):481-485

Mapping of the gene encoding the B56 beta subunit of protein phosphatase 2A (PPP2R5B) to a 0.5-Mb region of chromosome 11q13 and its exclusion as a candidate gene for multiple endocrine neoplasia type 1 (MEN1).

Forbes SA; Pannett AA; Bassett JH; Harding B; Wooding C; Thakker RV; Butler R; Ogilvie D; Anand R; Gaudray P; Weber G; Larsson C; Zhang CX; Calender A; Höppener JW; Lips CJ; Kas K
Article: HUMAN MOLECULAR GENETICS. 1997;6(7):1177-1183

Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.

Lemmens I; Van de Ven WJ; Kas K; Zhang CX; Giraud S; Wautot V; Buisson N; De Witte K; Salandre J; Lenoir G; Pugeat M; Calender A; Parente F; Quincey D; Gaudray P; De Wit MJ; Lips CJ; Höppener JW; Khodaei S; Grant AL; Weber G; Kytölä S; Teh BT; Farnebo F; Thakker RV
Article: MAMMALIAN GENOME. 1997;8(7):513-515

The mouse homologs of RELA and MLK3 are located within a 120-kb fragment on chromosome 19.

Fernandes M; Poirier C; Lassam NJ; Larsson C; Guénet J; Gaudray P; Carle GF
Article: HUMAN GENETICS. 1997;99(6):776-780

Fine mapping of the MLK-3 gene within 11q13 and its exclusion as the MEN1 susceptibility gene.

Lassam NJ; Lin Z; Shennan MG; Courseaux A; Teh BT; Gaudray P; Larsson C
Article: BRITISH JOURNAL OF SURGERY. 1997;163(5):331-337

Allelic loss on chromosome 11 is uncommon in parathyroid glands of patients with hypercalcaemic secondary hyperparathyroidism.

Farnebo F; Farnebo LO; Nordenström J; Larsson C
Article: JOURNAL OF CLINICAL NEUROSCIENCE. 1997;4(2):176-180

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy.

Sullivan AA; Teh BT; Jeavons S; Schalling M; Silburn P; Larsson C; Boyle R
Article: LANCET. 1997;349(9055):848-849

Familial non-VHL non-papillary clear-cell renal cancer.

Teh BT; Giraud S; Sari NF; Hii SI; Bergerat JP; Larsson C; Limacher JM; Nicol D
Article: HUMAN GENETICS. 1997;99(3):342-349

Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism.

Farnebo F; Teh BT; Dotzenrath C; Wassif WS; Svensson A; White I; Betz R; Goretzki P; Sandelin K; Farnebo LO; Larsson C
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1997;82(2):486-492

A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to the multiple endocrine neoplasia type 1 locus at chromosome region 11q13.

Stock JL; Warth MR; Teh BT; Coderre JA; Overdorf JH; Baumann G; Hintz RL; Hartman ML; Seizinger BR; Larsson C; Aronin N
Article: CANCER RESEARCH. 1997;57(3):500-503

Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinomas.

Marsh DJ; Zheng Z; Zedenius J; Kremer H; Padberg GW; Larsson C; Longy M; Eng C
Article: CLINICAL GENETICS. 1997;51(1):52-55

Oculopharyngeal muscular dystrophy (OPMD)--report and genetic studies of an Australian kindred.

Teh BT; Sullivan AA; Farnebo F; Zander C; Li FY; Strachan N; Schalling M; Larsson C; Sandstrom P
Article: MEDICINE. 1997;76(1):21-29

Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1.

Teh BT; McArdle J; Chan SP; Menon J; Hartley L; Pullan P; Ho J; Khir A; Wilkinson S; Larsson C; Cameron D; Shepherd J
Article: ACTA DERMATO-VENEREOLOGICA. 1997;77(1):4-9

Fine mapping of the locus for nevoid basal cell carcinoma syndrome on chromosome 9q.

Undén AB; Ståhle-Bäckdahl M; Holmberg E; Larsson C; Toftgård R
Article: HUMAN GENETICS. 1996;99(1):130-132

Exclusion of the phosphoinositide-specific phospholipase C beta 3 (PLCB3) gene as a candidate for multiple endocrine neoplasia type 1.

Weber G; Grimmond S; Lagercrantz J; Friedman E; Phelan C; Carson E; Hayward N; Jacobovitz O; Nordenskjöld M; Larsson C
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1996;81(12):4204-4211

Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas.

Teh BT; Farnebo F; Kristoffersson U; Sundelin B; Cardinal J; Axelson R; Yap A; Epstein M; Heath H; Cameron D; Larsson C
Article: GENOMICS. 1996;37(3):354-365

Definition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 11q13. The European Consortium on Men1, (GENEM 1; Groupe d'Etude des Néoplasies Endocriniennes Multiples de type 1).

Courseaux A; Grosgeorge J; Gaudray P; Pannett AA; Forbes SA; Williamson C; Bassett D; Thakker RV; Teh BT; Farnebo F; Shepherd J; Skogseid B; Larsson C; Giraud S; Zhang CX; Salandre J; Calender A
Article: ARCHIVES OF SURGERY. 1996;131(11):1230-1232

Sporadic primary hyperparathyroidism in the setting of multiple endocrine neoplasia type 1.

Teh BT; McArdle J; Parameswaran V; David R; Larsson C; Shepherd J
Article: CANCER RESEARCH. 1996;56(18):4219-4223

Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy.

Kjellman M; Kallioniemi OP; Karhu R; Höög A; Farnebo LO; Auer G; Larsson C; Bäckdahl M
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1996;81(9):3194-3196

Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors?

Dotzenrath C; Teh BT; Farnebo F; Cupisti K; Svensson A; Toell A; Goretzki P; Larsson C
Article: GENOMICS. 1996;35(3):633-635

A human homologue of the rat rab geranylgeranyl transferase beta subunit on chromosome 1p22-p31.

Sanders R; Islam KB; Betz R; Larsson C; Smith CI
Article: GENOMICS. 1996;34(1):63-68

The human mammary-derived growth inhibitor (MDGI) gene: genomic structure and mutation analysis in human breast tumors.

Phelan CM; Larsson C; Baird S; Futreal PA; Ruttledge MH; Morgan K; Tonin P; Hung H; Korneluk RG; Pollak MN; Narod SA
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1996;81(4):1312-1317

Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains.

Heath H; Odelberg S; Jackson CE; Teh BT; Hayward N; Larsson C; Buist NR; Krapcho KJ; Hung BC; Capuano IV; Garrett JE; Leppert MF
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1996;220(1):147-152

Expression of the VEGF-related factor gene in pre- and postnatal mouse.

Lagercrantz J; Larsson C; Grimmond S; Fredriksson M; Weber G; Piehl F
Article: HUMAN GENETICS. 1996;97(3):299-303

Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors.

Zedenius J; Wallin G; Svensson A; Bovèe J; Höög A; Bäckdahl M; Larsson C
Article: GENOMICS. 1996;31(3):380-384

Isolation and characterization of a novel gene close to the human phosphoinositide-specific phospholipase C beta 3 gene on chromosomal region 11q13.

Lagercrantz J; Carson E; Larsson C; Nordenskjöld M; Weber G
Article: THYROID. 1996;6(1):1-9

Alterations of p53 and expression of WAF1/p21 in human thyroid tumors.

Zedenius J; Larsson C; Wallin G; Bäckdahl M; Aspenblad U; Höög A; Børresen AL; Auer G
Article: WORLD JOURNAL OF SURGERY. 1996;20(1):101-106

Stromal fibroblasts adjacent to invasive thyroid tumors: expression of gelatinase A but not stromelysin 3 mRNA.

Zedenius J; Ståhle-Bäckdahl M; Enberg U; Grimelius L; Larsson C; Wallin G; Bäckdahl M
Article: NEUROREPORT. 1995;6(18):2542-2544

Expression of the phosphoinositide-specific phospholipase Cbeta3 gene in the rat.

Lagercrantz J; Piehl F; Nordenskjold M; Larsson C; Weber G
Article: GENOMICS. 1995;30(3):464-469

Chromosomal localization of six human forkhead genes, freac-1 (FKHL5), -3 (FKHL7), -4 (FKHL8), -5 (FKHL9), -6 (FKHL10), and -8 (FKHL12).

Larsson C; Hellqvist M; Pierrou S; White I; Enerbäck S; Carlsson P
Article: SURGERY. 1995;118(6):924-930

Hyperparathyroidism of multiple endocrine neoplasia type 1: candidate gene and parathyroid calcium sensing protein expression.

Carling T; Rastad J; Ridefelt P; Gobl A; Hellman P; Oberg K; Rask L; Larsson C; Juhlin C; Akerström G
Article: SURGERY. 1995;118(6):1077-1082

Adrenal lesion in multiple endocrine neoplasia type 1.

Skogseid B; Rastad J; Gobl A; Larsson C; Backlin K; Juhlin C; Akerström G; Oberg K
Article: JOURNAL OF INTERNAL MEDICINE. 1995;238(3):249-253

Genetic mapping of the multiple endocrine neoplasia type 1 locus at 11q13.

Teh BT; Cardinal J; Shepherd J; Hayward NK; Weber G; Cameron D; Larsson C
Article: JOURNAL OF INTERNAL MEDICINE. 1995;238(3):245-248

Candidate genes for multiple endocrine neoplasia type 1.

Lagercrantz J; Larsson C; Grimmond S; Skogseid B; Gobl A; Friedman E; Carson E; Phelan C; Oberg K; Nordenskjöld M
Article: JOURNAL OF INTERNAL MEDICINE. 1995;238(3):239-244

Molecular tools for presymptomatic testing in multiple endocrine neoplasia type 1.

Larsson C; Calender A; Grimmond S; Giraud S; Hayward NK; Teh B; Farnebo F
Article: LEUKEMIA. 1995;9(8):1313-1317

Rearrangement of proximal 11q13 band in a CMML in acute transformation.

Courseaux A; Grosgeorge J; Garnier G; Larsson C; Ayraud N; Gaudray P; Raynaud SD
Article: HUMAN GENETICS. 1995;96(1):27-32

Allelotyping of follicular thyroid tumors.

Zedenius J; Wallin G; Svensson A; Grimelius L; Höög A; Lundell G; Bäckdahl M; Larsson C
Article: GENES CHROMOSOMES & CANCER. 1995;13(3):203-210

High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium.

Cornelis RS; Neuhausen SL; Johansson O; Arason A; Kelsell D; Ponder BA; Tonin P; Hamann U; Lindblom A; Lalle P
Article: AMERICAN JOURNAL OF HUMAN GENETICS. 1995;56(6):1443-1449

Familial periodic cerebellar ataxia without myokymia maps to a 19-cM region on 19p13.

Teh BT; Silburn P; Lindblad K; Betz R; Boyle R; Schalling M; Larsson C
Article: GENOMICS. 1995;26(3):467-472

Genomic organization and complete cDNA sequence of the human phosphoinositide-specific phospholipase C beta 3 gene (PLCB3).

Lagercrantz J; Carson E; Phelan C; Grimmond S; Rosén A; Daré E; Nordenskjöld M; Hayward NK; Larsson C; Weber G
Article: JOURNAL OF IMMUNOLOGY. 1995;154(3):1265-1272

Molecular cloning, characterization, and chromosomal localization of a human lymphoid tyrosine kinase related to murine Blk.

Islam KB; Rabbani H; Larsson C; Sanders R; Smith CI
Article: LAKARTIDNINGEN. 1995;92(4):269-275

[The first breast cancer gene isolated. Safer risk assessment for affected families].

Iselius L; Larsson C; Lindblom A; Sandelin K; Wickman M; Wilking N
Article: CYTOGENETIC AND GENOME RESEARCH. 1995;71(3):257-259

Assignment of the mouse homologue of a human MEN1 candidate gene, phospholipase C-beta 3 (Plcb3), to chromosome region 19B by FISH.

Gobl AE; Chowdhary BP; Shu W; Eriksson L; Larsson C; Weber G; Oberg K; Skogseid B
Article: AMERICAN JOURNAL OF HUMAN GENETICS. 1995;56(1):254-264

An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.

Narod SA; Ford D; Devilee P; Barkardottir RB; Lynch HT; Smith SA; Ponder BA; Weber BL; Garber JE; Birch JM
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 1992;34(2):481-492

Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas.

Juhlin CC; Haglund F; Villablanca A; Forsberg L; Sandelin K; Bränström R; Larsson C; Höög A
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 1992;33(4):861-869

Gene-specific promoter hypermethylation without global hypomethylation in follicular thyroid cancer.

Lee J-J; Geli J; Larsson C; Wallin G; Karimi M; Zedenius J; Höög A; Foukakis T
Visa fler

Alla övriga publikationer

Corrigendum: NATURE METABOLISM. 2022;4(10):1421

Publisher Correction: Impaired oxygen-sensitive regulation of mitochondrial biogenesis within the von Hippel-Lindau syndrome.

Li S; Li W; Yuan J; Bullova P; Wu J; Zhang X; Liu Y; Plescher M; Rodriguez J; Bedoya-Reina OC; Jannig PR; Valente-Silva P; Yu M; Henriksson MA; Zubarev RA; Smed-Sörensen A; Suzuki CK; Ruas JL; Holmberg J; Larsson C; Christofer Juhlin C; von Kriegsheim A; Cao Y; Schlisio S
Review: LANCET DIABETES & ENDOCRINOLOGY. 2021;9(1):13-21

Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature.

Bancos I; Atkinson E; Eng C; Young WF; Neumann HPH; International Pheochromocytoma and Pregnancy Study
Review: ONCOGENE. 2019;38(34):6172-6183

Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.

Yuan X; Larsson C; Xu D
Letter: CLINICAL ENDOCRINOLOGY. 2018;88(2):343-345

Telomerase reverse transcriptase promoter hypermethylation is associated with metastatic disease in abdominal paraganglioma.

Svahn F; Juhlin CC; Paulsson JO; Fotouhi O; Zedenius J; Larsson C; Stenman A
Published conference paper: SURGERY. 2017;161(6):1667-1674

Overexpression of cytochrome P450 2A6 in adrenocortical carcinoma.

Murtha TD; Brown TC; Rubinstein JC; Haglund F; Juhlin CC; Larsson C; Korah R; Carling T
Letter: ENDOCRINE-RELATED CANCER. 2015;22(3):L9-L11

TERT promoter mutations are rare in parathyroid tumors.

Haglund F; Juhlin CC; Brown T; Ghaderi M; Liu T; Stenman A; Dinets A; Prasad M; Korah R; Xu D; Carling T; Larsson C
Letter: CLINICAL ENDOCRINOLOGY. 2010;73(4):552-553

Lack of S37A CTNNB1/β-catenin mutations in a Swedish cohort of 98 parathyroid adenomas.

Haglund F; Andreasson A; Nilsson I-L; Höög A; Larsson C; Juhlin CC
Meeting abstract: EUROPEAN JOURNAL OF CANCER, SUPPLEMENT. 2010;8(5):187

Altered expression of miR-205 affects cell proliferation in human cervical cancer

Xie H; Caramuta S; Larsson C; Lui WO
Meeting abstract: EUROPEAN JOURNAL OF CANCER, SUPPLEMENT. 2010;8(5):185

Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphomas

Caramuta S; Berglund M; Ozata D; Akcakaya P; Georgii-Hemming P; Xie H; Enblad G; Larsson C; Lui WO
Meeting abstract: EUROPEAN JOURNAL OF CANCER, SUPPLEMENT. 2010;8(5):224

The involvement of miR-483 and its host gene IGF2 in development of adrenal cortical carcinoma

Ozata D; Caramuta S; Akcakaya P; Xie HONG; Backdahl M; Larsson C; Lui W
Meeting abstract: BLOOD. 2004;104(11):431A

DLEU2, located within the CLL 13q14 deletion locus, encodes an antisense RNA for the putative bicistronic RFP2/LEU5 gene in humans and mouse

Corcoran MM; Hammarsund M; Zhu CY; Lerner M; Kapanadze B; Larsson C; Forsberg L; Ibbotson RE; Einhorn S; Oscier DG; Grander D; Sangfelt O
Published conference paper: BRITISH JOURNAL OF SURGERY. 2002;88(4):557-563

Expression of the RET proto-oncogene in papillary thyroid carcinoma and its correlation with clinical outcome.

Kjellman P; Learoyd DL; Messina M; Weber G; Höög A; Wallin G; Larsson C; Robinson BG; Zedenius J
Published conference paper: WORLD JOURNAL OF SURGERY. 2002;26(8):965-971

Loss of heterozygosity on the short arm of chromosome 1 in pheochromocytoma and abdominal paraganglioma.

Edström Elder E; Nord B; Carling T; Juhlin C; Bäckdahl M; Höög A; Larsson C
Published conference paper: WORLD JOURNAL OF SURGERY. 2002;26(8):907-913

Genetic screening for MEN1 mutations in families presenting with familial primary hyperparathyroidism.

Perrier ND; Villablanca A; Larsson C; Wong M; Ituarte P; Teh BT; Clark OH
Letter: JOURNAL OF MEDICAL GENETICS. 2001;38(3):185-189

Founder effect in multiple endocrine neoplasia type 1 (MEN 1) in Finland.

Kytölä S; Villablanca A; Ebeling T; Nord B; Larsson C; Höög A; Wong FK; Välimäki M; Vierimaa O; Teh BT; Salmela PI; Leisti J
Review: SEMINARS IN CANCER BIOLOGY. 2000;10(4):299-312

Multiple endocrine neoplasia type 1.

Ki Wong F; Burgess J; Nordenskjöld M; Larsson C; Tean Teh B
Editorial comment: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2000;85(5):1752-1754

Dissecting the genetics of hyperparathyroidism--new clues from an old friend.

Larsson C
Published conference paper: SURGERY. 1999;126(6):1183-1187

Expression of matrix metalloproteinase gelatinase A messenger ribonucleic acid in parathyroid carcinomas.

Farnebo F; Svensson A; Thompson NW; Bäckdahl M; Grimelius L; Larsson C; Farnebo LO; Sandelin K
Review: ANTICANCER RESEARCH. 1999;19(6A):4715-4728

Tumor suppressor genes (TSG).

Teh BT; Larsson C; Nordenskjöld M
Letter: JOURNAL OF MEDICAL GENETICS. 1999;36(4):348-349

Familial testicular cancer: lack of evidence for trinucleotide repeat expansions and association with PKD1 in one family.

Teh BT; Linblad K; Nord B; Kytölä S; Schalling M; Larsson C; Rapley E; Biggs P; Huddart R; Stratton M
Published conference paper: SURGERY. 1998;124(6):1094-1098

Decreased expression of calcium-sensing receptor messenger ribonucleic acids in parathyroid adenomas.

Farnebo F; Höög A; Sandelin K; Larsson C; Farnebo LO
Letter: AMERICAN JOURNAL OF HUMAN GENETICS. 1998;63(5):1544-1549

A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors.

Teh BT; Esapa CT; Houlston R; Grandell U; Farnebo F; Nordenskjöld M; Pearce CJ; Carmichael D; Larsson C; Harris PE
Published conference paper: JOURNAL OF INTERNAL MEDICINE. 1998;243(6):441-446

The search for the MEN1 gene. The European Consortium on MEN-1.
Published conference paper: ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 1998;841:181-183

Congenital myasthenic syndromes. Studies of the AChR and other candidate genes.

Beeson D; Newland C; Croxen R; Buckel A; Li FY; Larsson C; Tariq M; Vincent A; Newsom-Davis J
Letter: AMERICAN JOURNAL OF NEURORADIOLOGY. 1997;18(5):991-992

Gene identification in autosomal dominant disorders.

Teh BT; Lagercrantz J; Weber G; Larsson C
Published conference paper: HORMONE RESEARCH IN PAEDIATRICS. 1997;47(4-6):179-184

Multiple endocrine neoplasia type 1 and the search for the genetic trigger.

Farnebo F; Järhult J; Farnebo LO; Nilsson O; Teh BT; Lagercrantz J; Weber G; Sandelin K; Larsson C
Letter: NATURE GENETICS. 1996;13(2):238-240

BRCA2 mutations in primary breast and ovarian cancers.

Lancaster JM; Wooster R; Mangion J; Phelan CM; Cochran C; Gumbs C; Seal S; Barfoot R; Collins N; Bignell G; Patel S; Hamoudi R; Larsson C; Wiseman RW; Berchuck A; Iglehart JD; Marks JR; Ashworth A; Stratton MR; Futreal PA
Letter: NATURE GENETICS. 1996;13(1):120-122

Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.

Phelan CM; Lancaster JM; Tonin P; Gumbs C; Cochran C; Carter R; Ghadirian P; Perret C; Moslehi R; Dion F; Faucher MC; Dole K; Karimi S; Foulkes W; Lounis H; Warner E; Goss P; Anderson D; Larsson C; Narod SA; Futreal PA
Letter: NATURE GENETICS. 1996;12(3):309-311

Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.

Phelan CM; Rebbeck TR; Weber BL; Devilee P; Ruttledge MH; Lynch HT; Lenoir GM; Stratton MR; Easton DF; Ponder BA; Cannon-Albright L; Larsson C; Goldgar DE; Narod SA
Published conference paper: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES. 1996;104 Suppl 4:105-107

Molecular genetics of primary and secondary hyperparathyroidism.

Dotzenrath C; Goretzki PE; Farnebo F; Teh BT; Weber G; Röher HD; Larsson C
Other: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1995;80(10):3088-3090

Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas.

Zedenius J; Larsson C; Bergholm U; Bovée J; Svensson A; Hallengren B; Grimelius L; Bäckdahl M; Weber G; Wallin G
Review: ANZ JOURNAL OF SURGERY. 1995;65(10):708-713

Multiple endocrine neoplasia type I: clinical syndrome to molecular genetics.

Teh BT; Grimmond S; Shepherd J; Larsson C; Hayward N
Other: CANCER RESEARCH. 1995;55(11):2225-2231

Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor.

Huynh HT; Larsson C; Narod S; Pollak M
Other: HUMAN GENETICS. 1995;95(4):455-458

Exclusion of the 13-kDa rapamycin binding protein gene (FKBP2) as a candidate gene for multiple endocrine neoplasia type 1.

Grimmond S; Weber G; Larsson C; Walters M; Teh B; Shepherd J; Nordenskjold M; Hayward N
Other: HUMAN GENETICS. 1995;95(3):356-358

Localization of the human soluble epoxide hydrolase gene (EPHX2) to chromosomal region 8p21-p12.

Larsson C; White I; Johansson C; Stark A; Meijer J
Visa fler

Om mig

Forskningsbeskrivning

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI